| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coactivator activity | NCOA2 BCL9L NCOA6 SMARCA4 SMARCC1 SMARCD3 BCL9 SS18 CREBBP EP300 ZIC3 | 8.24e-08 | 303 | 87 | 11 | GO:0003713 |
| GeneOntologyMolecularFunction | transcription factor binding | NCOA2 FOXO1 MSX2 NCOA6 SALL1 NR4A2 SMARCA4 SMARCD3 SALL4 REST CREBBP EP300 MEIS2 HDAC1 STAT6 | 8.12e-07 | 753 | 87 | 15 | GO:0008134 |
| GeneOntologyMolecularFunction | beta-catenin binding | 9.32e-07 | 120 | 87 | 7 | GO:0008013 | |
| GeneOntologyMolecularFunction | nuclear glucocorticoid receptor binding | 1.54e-06 | 20 | 87 | 4 | GO:0035259 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 2.62e-06 | 140 | 87 | 7 | GO:0001221 | |
| GeneOntologyMolecularFunction | chromatin binding | NCOA2 FOXO1 TRIM33 NCOA6 SALL1 TOX SMARCA4 SMARCC1 ANKRD17 SMARCD3 REST CREBBP EP300 HDAC1 | 3.54e-06 | 739 | 87 | 14 | GO:0003682 |
| GeneOntologyMolecularFunction | transcription coregulator activity | NCOA2 BCL9L NCOA6 SMARCA4 SMARCC1 SMARCD3 BCL9 SS18 CREBBP EP300 HDAC1 ZIC3 | 5.71e-06 | 562 | 87 | 12 | GO:0003712 |
| GeneOntologyMolecularFunction | chromatin DNA binding | 8.41e-06 | 167 | 87 | 7 | GO:0031490 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | NCOA2 FOXO1 MSX2 SALL1 ZFHX4 LMX1B ZBED2 NR4A2 SMARCA4 SALL4 KLF17 REST ZNF281 CREBBP EP300 MEIS2 HDAC1 STAT6 ZIC3 | 1.32e-05 | 1459 | 87 | 19 | GO:0000977 |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | NCOA2 NCOA6 SALL1 NR4A2 SMARCA4 SMARCD3 REST CREBBP EP300 HDAC1 | 1.35e-05 | 417 | 87 | 10 | GO:0061629 |
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 1.88e-05 | 2 | 87 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 1.88e-05 | 2 | 87 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | NCOA2 FOXO1 MSX2 SALL1 ZFHX4 NR4A2 SMARCA4 SALL4 KLF17 REST ZNF281 EP300 MEIS2 TIPARP HDAC1 STAT6 ZIC3 | 2.93e-05 | 1271 | 87 | 17 | GO:0000987 |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 5.61e-05 | 3 | 87 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | NCOA2 FOXO1 MSX2 SALL1 ZFHX4 NR4A2 SMARCA4 SALL4 KLF17 REST ZNF281 EP300 MEIS2 HDAC1 STAT6 ZIC3 | 8.30e-05 | 1244 | 87 | 16 | GO:0000978 |
| GeneOntologyMolecularFunction | transcription coactivator binding | 9.00e-05 | 54 | 87 | 4 | GO:0001223 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 1.00e-04 | 21 | 87 | 3 | GO:0042975 | |
| GeneOntologyMolecularFunction | nuclear retinoid X receptor binding | 1.33e-04 | 23 | 87 | 3 | GO:0046965 | |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 1.45e-04 | 61 | 87 | 4 | GO:0030374 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 1.68e-04 | 187 | 87 | 6 | GO:0016922 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | NCOA2 NCOA6 SALL1 NR4A2 SMARCA4 SMARCD3 REST CREBBP EP300 HDAC1 | 2.18e-04 | 582 | 87 | 10 | GO:0140297 |
| GeneOntologyMolecularFunction | retinoic acid binding | 2.42e-04 | 28 | 87 | 3 | GO:0001972 | |
| GeneOntologyMolecularFunction | MAP kinase kinase kinase kinase activity | 2.78e-04 | 6 | 87 | 2 | GO:0008349 | |
| GeneOntologyMolecularFunction | p53 binding | 3.57e-04 | 77 | 87 | 4 | GO:0002039 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | NCOA2 BCL9L SRRT NCOA6 SNAP91 SMARCA4 SMARCC1 SMARCD3 BCL9 SS18 CREBBP EP300 HDAC1 ZIC3 | 4.66e-04 | 1160 | 87 | 14 | GO:0030674 |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 4.73e-04 | 35 | 87 | 3 | GO:0015020 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 4.75e-04 | 83 | 87 | 4 | GO:1990841 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 4.96e-04 | 320 | 87 | 7 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 5.54e-04 | 326 | 87 | 7 | GO:0001217 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | FOXO1 MSX2 SALL1 ZFHX4 LMX1B ZBED2 NR4A2 SALL4 KLF17 REST SP110 ZNF281 MEIS2 STAT6 ZIC3 | 1.08e-03 | 1412 | 87 | 15 | GO:0000981 |
| GeneOntologyMolecularFunction | retinoid binding | 1.20e-03 | 48 | 87 | 3 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 1.27e-03 | 49 | 87 | 3 | GO:0019840 | |
| GeneOntologyMolecularFunction | pre-mRNA intronic binding | 1.65e-03 | 14 | 87 | 2 | GO:0097157 | |
| GeneOntologyMolecularFunction | core promoter sequence-specific DNA binding | 1.78e-03 | 55 | 87 | 3 | GO:0001046 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 1.78e-03 | 55 | 87 | 3 | GO:0042974 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 1.90e-03 | 15 | 87 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | NCOA2 BCL9L SRRT NCOA6 SNAP91 SMARCA4 SMARCC1 SMARCD3 BCL9 SS18 CREBBP EP300 HDAC1 ZIC3 | 2.10e-03 | 1356 | 87 | 14 | GO:0060090 |
| GeneOntologyMolecularFunction | nucleosomal DNA binding | 3.13e-03 | 67 | 87 | 3 | GO:0031492 | |
| GeneOntologyMolecularFunction | DNA polymerase binding | 4.47e-03 | 23 | 87 | 2 | GO:0070182 | |
| GeneOntologyMolecularFunction | RNA polymerase II core promoter sequence-specific DNA binding | 5.27e-03 | 25 | 87 | 2 | GO:0000979 | |
| GeneOntologyMolecularFunction | SMAD binding | 6.30e-03 | 86 | 87 | 3 | GO:0046332 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 8.04e-03 | 31 | 87 | 2 | GO:0140033 | |
| GeneOntologyMolecularFunction | nucleosome binding | 9.02e-03 | 98 | 87 | 3 | GO:0031491 | |
| GeneOntologyMolecularFunction | nuclear androgen receptor binding | 9.08e-03 | 33 | 87 | 2 | GO:0050681 | |
| GeneOntologyBiologicalProcess | stem cell population maintenance | FOXO1 BCL9L SRRT SALL1 SMARCA4 SMARCC1 SALL4 REST BCL9 SS18 CREBBP HDAC1 ZIC3 | 1.33e-11 | 237 | 84 | 13 | GO:0019827 |
| GeneOntologyBiologicalProcess | maintenance of cell number | FOXO1 BCL9L SRRT SALL1 SMARCA4 SMARCC1 SALL4 REST BCL9 SS18 CREBBP HDAC1 ZIC3 | 1.73e-11 | 242 | 84 | 13 | GO:0098727 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | TGFB3 NCOA2 ZNF462 FOXO1 BCL9L NCOA6 SALL1 TOX LMX1B TNFSF8 ZBED2 NR4A2 SMARCA4 SMARCC1 SALL4 REST SSBP4 BCL9 SS18 CREBBP EP300 MEIS2 HDAC1 STAT6 ZIC3 | 1.35e-10 | 1390 | 84 | 25 | GO:0045944 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | NCOA2 FOXO1 MSX2 TRIM33 ZNF469 MAGEL2 SALL1 ZBED2 NR4A2 SMARCA4 SALL4 KLF17 REST ZNF281 CREBBP EP300 MEIS2 HDAC1 SCAF4 STAT6 | 5.75e-09 | 1053 | 84 | 20 | GO:0000122 |
| GeneOntologyBiologicalProcess | head development | TGFB3 CACNA1A NCOA6 SALL1 TOX ATG7 ATXN2 LMX1B MINK1 NR4A2 SMARCA4 CREBBP EP300 MEIS2 TIPARP HDAC1 ZIC3 | 1.42e-07 | 919 | 84 | 17 | GO:0060322 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | NCOA2 FOXO1 MSX2 TRIM33 ZNF469 MAGEL2 SALL1 ZBED2 NR4A2 SMARCA4 SALL4 KLF17 REST ZNF281 CREBBP EP300 MEIS2 HDAC1 SCAF4 STAT6 | 6.04e-07 | 1399 | 84 | 20 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | NCOA2 FOXO1 MSX2 TRIM33 ZNF469 MAGEL2 SALL1 ZBED2 NR4A2 SMARCA4 SALL4 KLF17 REST ZNF281 CREBBP EP300 MEIS2 HDAC1 SCAF4 STAT6 | 7.06e-07 | 1413 | 84 | 20 | GO:1902679 |
| GeneOntologyBiologicalProcess | appendage morphogenesis | 8.77e-07 | 185 | 84 | 8 | GO:0035107 | |
| GeneOntologyBiologicalProcess | limb morphogenesis | 8.77e-07 | 185 | 84 | 8 | GO:0035108 | |
| GeneOntologyBiologicalProcess | positive regulation of stem cell population maintenance | 2.01e-06 | 51 | 84 | 5 | GO:1902459 | |
| GeneOntologyBiologicalProcess | embryonic limb morphogenesis | 2.42e-06 | 148 | 84 | 7 | GO:0030326 | |
| GeneOntologyBiologicalProcess | embryonic appendage morphogenesis | 2.42e-06 | 148 | 84 | 7 | GO:0035113 | |
| GeneOntologyBiologicalProcess | neuronal stem cell population maintenance | 3.57e-06 | 26 | 84 | 4 | GO:0097150 | |
| GeneOntologyBiologicalProcess | limb development | 3.66e-06 | 224 | 84 | 8 | GO:0060173 | |
| GeneOntologyBiologicalProcess | appendage development | 3.66e-06 | 224 | 84 | 8 | GO:0048736 | |
| GeneOntologyBiologicalProcess | response to hormone | TGFB3 NCOA2 FOXO1 NCOA6 KANK1 ZBED2 SLC26A5 NR4A2 SMARCA4 SMARCC1 PRKCI REST MN1 EP300 HDAC1 STAT6 | 4.01e-06 | 1042 | 84 | 16 | GO:0009725 |
| GeneOntologyBiologicalProcess | face development | 5.80e-06 | 63 | 84 | 5 | GO:0060324 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | TGFB3 MSX2 SALL1 LMX1B SOBP CECR2 SMARCA4 SALL4 REST ZNF281 CREBBP HDAC1 ZIC3 | 5.89e-06 | 713 | 84 | 13 | GO:0048598 |
| GeneOntologyBiologicalProcess | body morphogenesis | 6.27e-06 | 64 | 84 | 5 | GO:0010171 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | TGFB3 MSX2 SALL1 SOBP SMARCA4 SMARCC1 SMARCD3 PRKCI REST USH2A RBM20 EP300 MEIS2 TIPARP HDAC1 STAT6 ZIC3 | 1.17e-05 | 1269 | 84 | 17 | GO:0009887 |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | TGFB3 MSX2 BCL9L SRRT FNDC3B SALL1 TOX SNAP91 ZBED2 SMARCA4 SMARCC1 SMARCD3 PRKCI REST EP300 HDAC1 | 1.26e-05 | 1141 | 84 | 16 | GO:0045597 |
| GeneOntologyBiologicalProcess | regulation of transforming growth factor beta receptor signaling pathway | 1.34e-05 | 192 | 84 | 7 | GO:0017015 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to transforming growth factor beta stimulus | 1.48e-05 | 195 | 84 | 7 | GO:1903844 | |
| GeneOntologyBiologicalProcess | embryo development | TGFB3 MSX2 NCOA6 SALL1 LMX1B SOBP CECR2 ZBED2 SMARCA4 SALL4 REST HSD17B2 ZNF281 CREBBP EP300 MEIS2 HDAC1 ZIC3 | 1.54e-05 | 1437 | 84 | 18 | GO:0009790 |
| GeneOntologyBiologicalProcess | regulation of stem cell population maintenance | 1.66e-05 | 78 | 84 | 5 | GO:2000036 | |
| GeneOntologyBiologicalProcess | myoblast differentiation | 1.96e-05 | 136 | 84 | 6 | GO:0045445 | |
| GeneOntologyBiologicalProcess | face morphogenesis | 2.31e-05 | 41 | 84 | 4 | GO:0060325 | |
| GeneOntologyBiologicalProcess | cellular response to hormone stimulus | NCOA2 FOXO1 KANK1 NR4A2 SMARCA4 SMARCC1 PRKCI REST MN1 EP300 HDAC1 STAT6 | 3.71e-05 | 727 | 84 | 12 | GO:0032870 |
| GeneOntologyBiologicalProcess | sensory organ development | TGFB3 LMX1B SOBP CECR2 SLC26A5 SMARCA4 PRKCI REST USH2A MEIS2 HDAC1 ZIC3 | 3.86e-05 | 730 | 84 | 12 | GO:0007423 |
| GeneOntologyBiologicalProcess | brain development | CACNA1A NCOA6 SALL1 TOX ATG7 ATXN2 LMX1B MINK1 NR4A2 SMARCA4 MEIS2 HDAC1 ZIC3 | 4.19e-05 | 859 | 84 | 13 | GO:0007420 |
| GeneOntologyBiologicalProcess | head morphogenesis | 4.34e-05 | 48 | 84 | 4 | GO:0060323 | |
| GeneOntologyBiologicalProcess | heart development | TGFB3 MSX2 NCOA6 SALL1 ATG7 SMARCA4 SMARCD3 SALL4 REST RBM20 EP300 ZIC3 | 5.48e-05 | 757 | 84 | 12 | GO:0007507 |
| GeneOntologyBiologicalProcess | somatic stem cell population maintenance | 7.97e-05 | 108 | 84 | 5 | GO:0035019 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 8.22e-05 | 21 | 84 | 3 | GO:0052695 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 8.49e-05 | 347 | 84 | 8 | GO:0090092 | |
| GeneOntologyBiologicalProcess | viral transcription | 9.18e-05 | 58 | 84 | 4 | GO:0019083 | |
| GeneOntologyBiologicalProcess | nucleosome disassembly | 9.49e-05 | 22 | 84 | 3 | GO:0006337 | |
| GeneOntologyBiologicalProcess | frontal suture morphogenesis | 9.78e-05 | 4 | 84 | 2 | GO:0060364 | |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-lysine acetylation | 9.78e-05 | 4 | 84 | 2 | GO:0018076 | |
| GeneOntologyBiologicalProcess | negative regulation of developmental process | FOXO1 MSX2 FNDC3B KANK1 SALL1 ATXN2 SMARCA4 SMARCC1 ANKRD17 REST USH2A SS18 MAP4K4 MEIS2 HDAC1 | 1.09e-04 | 1220 | 84 | 15 | GO:0051093 |
| GeneOntologyBiologicalProcess | protein-DNA complex disassembly | 1.24e-04 | 24 | 84 | 3 | GO:0032986 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor signaling pathway | 1.34e-04 | 276 | 84 | 7 | GO:0007179 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 1.58e-04 | 26 | 84 | 3 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 1.58e-04 | 26 | 84 | 3 | GO:0006063 | |
| GeneOntologyBiologicalProcess | cellular response to hyperoxia | 1.63e-04 | 5 | 84 | 2 | GO:0071455 | |
| GeneOntologyBiologicalProcess | ear development | 1.63e-04 | 285 | 84 | 7 | GO:0043583 | |
| GeneOntologyBiologicalProcess | T cell differentiation | 1.65e-04 | 382 | 84 | 8 | GO:0030217 | |
| GeneOntologyBiologicalProcess | T cell selection | 1.81e-04 | 69 | 84 | 4 | GO:0045058 | |
| GeneOntologyBiologicalProcess | negative regulation of cell differentiation | FOXO1 MSX2 FNDC3B SALL1 SMARCA4 SMARCC1 ANKRD17 REST USH2A SS18 MEIS2 HDAC1 | 2.14e-04 | 875 | 84 | 12 | GO:0045596 |
| GeneOntologyBiologicalProcess | regulation of nucleotide-excision repair | 2.21e-04 | 29 | 84 | 3 | GO:2000819 | |
| GeneOntologyBiologicalProcess | embryonic digit morphogenesis | 2.37e-04 | 74 | 84 | 4 | GO:0042733 | |
| GeneOntologyBiologicalProcess | Wnt signaling pathway | 2.49e-04 | 516 | 84 | 9 | GO:0016055 | |
| GeneOntologyBiologicalProcess | central nervous system neuron differentiation | 2.60e-04 | 217 | 84 | 6 | GO:0021953 | |
| GeneOntologyBiologicalProcess | chromatin organization | ZNF462 TOX ATG7 CECR2 SMARCA4 SMARCC1 SMARCD3 REST SS18 CREBBP EP300 HDAC1 | 2.66e-04 | 896 | 84 | 12 | GO:0006325 |
| GeneOntologyBiologicalProcess | CD4-positive, alpha-beta T cell lineage commitment | 2.70e-04 | 31 | 84 | 3 | GO:0043373 | |
| GeneOntologyBiologicalProcess | regulation of androgen receptor signaling pathway | 2.70e-04 | 31 | 84 | 3 | GO:0060765 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 2.74e-04 | 412 | 84 | 8 | GO:0090287 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | TGFB3 FOXO1 MSX2 TRIM33 BCL9L KANK1 SMARCC1 BCL9 SS18 CREBBP EP300 TIPARP HDAC1 STAT6 | 2.90e-04 | 1186 | 84 | 14 | GO:0007167 |
| GeneOntologyBiologicalProcess | cell morphogenesis | CACNA1A BCL9L KANK1 SNAP91 ATG7 ATXN2 MINK1 SLC26A5 NR4A2 SMARCA4 REST SS18 MAP4K4 EP300 | 3.10e-04 | 1194 | 84 | 14 | GO:0000902 |
| GeneOntologyBiologicalProcess | alpha-beta T cell lineage commitment | 3.25e-04 | 33 | 84 | 3 | GO:0002363 | |
| GeneOntologyBiologicalProcess | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment | 3.88e-04 | 35 | 84 | 3 | GO:0043369 | |
| GeneOntologyBiologicalProcess | hemopoiesis | NCOA6 TOX ATG7 PRRC2C TNFSF8 MINK1 SMARCA4 SMARCC1 SMARCD3 REST EP300 MEIS2 TIPARP STAT6 | 3.96e-04 | 1223 | 84 | 14 | GO:0030097 |
| GeneOntologyBiologicalProcess | regulation of intracellular steroid hormone receptor signaling pathway | 4.41e-04 | 87 | 84 | 4 | GO:0033143 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 4.43e-04 | 336 | 84 | 7 | GO:0071560 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 4.59e-04 | 445 | 84 | 8 | GO:0141091 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 5.00e-04 | 343 | 84 | 7 | GO:0071559 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle G1/S phase transition | 5.06e-04 | 246 | 84 | 6 | GO:1902806 | |
| GeneOntologyBiologicalProcess | canonical Wnt signaling pathway | 5.09e-04 | 344 | 84 | 7 | GO:0060070 | |
| GeneOntologyBiologicalProcess | modulation by host of symbiont process | 5.23e-04 | 91 | 84 | 4 | GO:0051851 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte differentiation | 5.26e-04 | 162 | 84 | 5 | GO:0045621 | |
| GeneOntologyBiologicalProcess | cerebellar Purkinje cell layer development | 5.36e-04 | 39 | 84 | 3 | GO:0021680 | |
| GeneOntologyBiologicalProcess | regulation of protein secretion | 5.64e-04 | 350 | 84 | 7 | GO:0050708 | |
| GeneOntologyBiologicalProcess | vitamin D3 metabolic process | 5.79e-04 | 9 | 84 | 2 | GO:0070640 | |
| GeneOntologyBiologicalProcess | inner ear development | 5.87e-04 | 253 | 84 | 6 | GO:0048839 | |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair | 6.15e-04 | 95 | 84 | 4 | GO:2000781 | |
| GeneOntologyBiologicalProcess | neuron projection development | CACNA1A KANK1 TOX SNAP91 ATG7 ATXN2 CECR2 MINK1 NR4A2 PRKCI REST MAP4K4 CREBBP EP300 | 6.47e-04 | 1285 | 84 | 14 | GO:0031175 |
| GeneOntologyBiologicalProcess | circulatory system development | TGFB3 FOXO1 MSX2 NCOA6 SALL1 ATG7 SMARCA4 ANKRD17 SMARCD3 SALL4 REST RBM20 EP300 TIPARP ZIC3 | 6.58e-04 | 1442 | 84 | 15 | GO:0072359 |
| GeneOntologyBiologicalProcess | rhythmic process | 6.66e-04 | 360 | 84 | 7 | GO:0048511 | |
| GeneOntologyBiologicalProcess | regulation of G0 to G1 transition | 6.67e-04 | 42 | 84 | 3 | GO:0070316 | |
| GeneOntologyBiologicalProcess | T cell lineage commitment | 6.67e-04 | 42 | 84 | 3 | GO:0002360 | |
| GeneOntologyBiologicalProcess | response to glucose | 6.77e-04 | 260 | 84 | 6 | GO:0009749 | |
| GeneOntologyBiologicalProcess | cellular response to oxygen-containing compound | NCOA2 FOXO1 CACNA1A MSX2 NCOA6 KANK1 ATG7 NR4A2 SMARCA4 SMARCC1 PRKCI MAP4K4 MN1 EP300 STAT6 | 6.96e-04 | 1450 | 84 | 15 | GO:1901701 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | ZNF462 TOX ATG7 CECR2 SMARCA4 SMARCC1 SMARCD3 REST SS18 CREBBP EP300 HDAC1 | 7.05e-04 | 999 | 84 | 12 | GO:0071824 |
| GeneOntologyBiologicalProcess | germ-line stem cell population maintenance | 7.22e-04 | 10 | 84 | 2 | GO:0030718 | |
| GeneOntologyBiologicalProcess | cranial suture morphogenesis | 7.22e-04 | 10 | 84 | 2 | GO:0060363 | |
| GeneOntologyBiologicalProcess | response to hexose | 7.48e-04 | 265 | 84 | 6 | GO:0009746 | |
| GeneOntologyBiologicalProcess | neuron development | CACNA1A KANK1 TOX SNAP91 ATG7 ATXN2 LMX1B CECR2 MINK1 NR4A2 PRKCI REST MAP4K4 CREBBP EP300 | 7.64e-04 | 1463 | 84 | 15 | GO:0048666 |
| GeneOntologyBiologicalProcess | G0 to G1 transition | 7.65e-04 | 44 | 84 | 3 | GO:0045023 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 7.74e-04 | 482 | 84 | 8 | GO:0007178 | |
| GeneOntologyBiologicalProcess | response to monosaccharide | 8.56e-04 | 272 | 84 | 6 | GO:0034284 | |
| GeneOntologyBiologicalProcess | positive regulation of cell development | 8.74e-04 | 614 | 84 | 9 | GO:0010720 | |
| GeneOntologyBiologicalProcess | negative regulation of hormone biosynthetic process | 8.80e-04 | 11 | 84 | 2 | GO:0032353 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA binding | 9.28e-04 | 47 | 84 | 3 | GO:0043392 | |
| GeneOntologyBiologicalProcess | cellular response to peptide hormone stimulus | 9.28e-04 | 381 | 84 | 7 | GO:0071375 | |
| GeneOntologyBiologicalProcess | viral gene expression | 1.03e-03 | 109 | 84 | 4 | GO:0019080 | |
| GeneOntologyBiologicalProcess | hindlimb morphogenesis | 1.05e-03 | 49 | 84 | 3 | GO:0035137 | |
| GeneOntologyBiologicalProcess | cellular response to increased oxygen levels | 1.05e-03 | 12 | 84 | 2 | GO:0036295 | |
| GeneOntologyBiologicalProcess | central nervous system development | CACNA1A NCOA6 SALL1 TOX ATG7 ATXN2 LMX1B MINK1 NR4A2 SMARCA4 MEIS2 HDAC1 ZIC3 | 1.06e-03 | 1197 | 84 | 13 | GO:0007417 |
| GeneOntologyBiologicalProcess | locomotory behavior | 1.07e-03 | 284 | 84 | 6 | GO:0007626 | |
| GeneOntologyBiologicalProcess | epidermal cell differentiation | 1.07e-03 | 284 | 84 | 6 | GO:0009913 | |
| GeneOntologyCellularComponent | chromatin | NCOA2 FOXO1 MSX2 TRIM33 SALL1 ZFHX4 LMX1B CECR2 ZBED2 NR4A2 SMARCA4 SMARCC1 ANKRD17 SMARCD3 SALL4 KLF17 REST SS18 CREBBP EP300 MEIS2 HDAC1 STAT6 | 1.14e-08 | 1480 | 84 | 23 | GO:0000785 |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 1.17e-07 | 96 | 84 | 7 | GO:0070603 | |
| GeneOntologyCellularComponent | npBAF complex | 2.35e-07 | 14 | 84 | 4 | GO:0071564 | |
| GeneOntologyCellularComponent | transcription regulator complex | NCOA2 MSX2 BCL9L NCOA6 SALL1 NR4A2 SALL4 REST BCL9 CREBBP EP300 HDAC1 STAT6 | 7.07e-07 | 596 | 84 | 13 | GO:0005667 |
| GeneOntologyCellularComponent | ATPase complex | 8.83e-07 | 129 | 84 | 7 | GO:1904949 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 6.14e-06 | 30 | 84 | 4 | GO:0016514 | |
| GeneOntologyCellularComponent | GBAF complex | 2.21e-05 | 14 | 84 | 3 | GO:0140288 | |
| GeneOntologyCellularComponent | nBAF complex | 3.38e-05 | 16 | 84 | 3 | GO:0071565 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | NCOA2 BCL9L CASC3 NCOA6 SALL1 WDR33 CECR2 SMARCA4 SMARCC1 SMARCD3 BCL9 SRRM2 SS18 CREBBP HDAC1 STAT6 | 1.03e-04 | 1377 | 84 | 16 | GO:0140513 |
| GeneOntologyCellularComponent | heterochromatin | 7.37e-04 | 101 | 84 | 4 | GO:0000792 | |
| GeneOntologyCellularComponent | beta-catenin-TCF complex | 1.21e-03 | 13 | 84 | 2 | GO:1990907 | |
| GeneOntologyCellularComponent | brahma complex | 1.41e-03 | 14 | 84 | 2 | GO:0035060 | |
| GeneOntologyCellularComponent | RSC-type complex | 1.62e-03 | 15 | 84 | 2 | GO:0016586 | |
| GeneOntologyCellularComponent | CHD-type complex | 2.09e-03 | 17 | 84 | 2 | GO:0090545 | |
| GeneOntologyCellularComponent | NuRD complex | 2.09e-03 | 17 | 84 | 2 | GO:0016581 | |
| GeneOntologyCellularComponent | vesicle coat | 2.49e-03 | 67 | 84 | 3 | GO:0030120 | |
| HumanPheno | Hypoplastic aortic arch | 1.78e-06 | 14 | 35 | 4 | HP:0012304 | |
| HumanPheno | Abnormal hallux phalanx morphology | 1.27e-05 | 46 | 35 | 5 | HP:0010057 | |
| HumanPheno | Spina bifida | 1.48e-05 | 171 | 35 | 8 | HP:0002414 | |
| HumanPheno | Abnormal spinal cord morphology | TGFB3 MSX2 SALL1 ATXN2 LMX1B SALL4 SRRM2 CREBBP EP300 SCAF4 ZIC3 | 1.55e-05 | 357 | 35 | 11 | HP:0002143 |
| HumanPheno | Broad hallux phalanx | 1.80e-05 | 24 | 35 | 4 | HP:0010059 | |
| HumanPheno | Spinal dysraphism | 2.74e-05 | 186 | 35 | 8 | HP:0010301 | |
| HumanPheno | Abnormal scrotum morphology | 4.13e-05 | 143 | 35 | 7 | HP:0000045 | |
| HumanPheno | Plantar crease between first and second toes | 4.59e-05 | 2 | 35 | 2 | HP:0008107 | |
| HumanPheno | Aortic isthmus hypoplasia | 4.59e-05 | 2 | 35 | 2 | HP:0034227 | |
| HumanPheno | High axial triradius | 4.59e-05 | 2 | 35 | 2 | HP:0001042 | |
| HumanPheno | Abnormal hallux morphology | 7.02e-05 | 212 | 35 | 8 | HP:0001844 | |
| HumanPheno | Parietal foramina | 1.03e-04 | 14 | 35 | 3 | HP:0002697 | |
| HumanPheno | Laryngeal cartilage malformation | 1.37e-04 | 3 | 35 | 2 | HP:0008752 | |
| HumanPheno | Phobia | 1.37e-04 | 3 | 35 | 2 | HP:5200232 | |
| HumanPheno | Agoraphobia | 1.37e-04 | 3 | 35 | 2 | HP:0000756 | |
| HumanPheno | Humoral immunodeficiency | 1.37e-04 | 3 | 35 | 2 | HP:0005363 | |
| HumanPheno | Prominent nasal septum | 1.37e-04 | 3 | 35 | 2 | HP:0005322 | |
| HumanPheno | Radial deviation of thumb terminal phalanx | 1.37e-04 | 3 | 35 | 2 | HP:0005895 | |
| HumanPheno | Abnormal eating behavior | 2.00e-04 | 128 | 35 | 6 | HP:0100738 | |
| HumanPheno | Meningioma | 2.09e-04 | 44 | 35 | 4 | HP:0002858 | |
| HumanPheno | Smooth philtrum | 2.11e-04 | 185 | 35 | 7 | HP:0000319 | |
| HumanPheno | Diagnostic behavioral phenotype | ZNF462 CACNA1A MAGEL2 ATG7 NR4A2 SMARCA4 ANKRD17 SRRM2 USH2A CREBBP EP300 SEC23B MEIS2 SCAF4 | 2.17e-04 | 747 | 35 | 14 | HP:0025783 |
| HumanPheno | Abnormal toe phalanx morphology | 2.17e-04 | 130 | 35 | 6 | HP:0010161 | |
| HumanPheno | Skin appendage neoplasm | 2.26e-04 | 18 | 35 | 3 | HP:0012842 | |
| HumanPheno | Broad phalanx of the toes | 2.70e-04 | 47 | 35 | 4 | HP:0010174 | |
| HumanPheno | Trichiasis | 2.73e-04 | 4 | 35 | 2 | HP:0001128 | |
| HumanPheno | Visceral hemangioma | 2.73e-04 | 4 | 35 | 2 | HP:0410266 | |
| HumanPheno | Talon cusp | 2.73e-04 | 4 | 35 | 2 | HP:0011087 | |
| HumanPheno | Widened distal phalanges | 2.73e-04 | 4 | 35 | 2 | HP:0006200 | |
| HumanPheno | Vascular ring | 2.73e-04 | 4 | 35 | 2 | HP:0010775 | |
| HumanPheno | Hepatic hemangioma | 2.73e-04 | 4 | 35 | 2 | HP:0031207 | |
| HumanPheno | Spondylolisthesis | 3.13e-04 | 20 | 35 | 3 | HP:0003302 | |
| HumanPheno | Insidious onset | 3.13e-04 | 20 | 35 | 3 | HP:0003587 | |
| HumanPheno | Autistic behavior | ZNF462 CACNA1A MAGEL2 ATG7 NR4A2 SMARCA4 ANKRD17 SRRM2 CREBBP EP300 SEC23B MEIS2 SCAF4 | 3.24e-04 | 678 | 35 | 13 | HP:0000729 |
| HumanPheno | Broad thumb | 3.29e-04 | 90 | 35 | 5 | HP:0011304 | |
| HumanPheno | Corneal scarring | 3.63e-04 | 21 | 35 | 3 | HP:0000559 | |
| HumanPheno | Narrow nasal bridge | 4.31e-04 | 53 | 35 | 4 | HP:0000446 | |
| HumanPheno | Broad phalanx | 4.39e-04 | 148 | 35 | 6 | HP:0006009 | |
| HumanPheno | Broad phalanges of the hand | 4.39e-04 | 148 | 35 | 6 | HP:0009768 | |
| HumanPheno | Papillary cystadenoma of the epididymis | 4.53e-04 | 5 | 35 | 2 | HP:0009715 | |
| HumanPheno | Supernumerary cusp | 4.53e-04 | 5 | 35 | 2 | HP:0033777 | |
| HumanPheno | Epididymal neoplasm | 4.53e-04 | 5 | 35 | 2 | HP:0030421 | |
| HumanPheno | Broad finger | 5.44e-04 | 154 | 35 | 6 | HP:0001500 | |
| HumanPheno | Temporal pattern | 5.45e-04 | 24 | 35 | 3 | HP:0011008 | |
| HumanPheno | Pes planus | 5.97e-04 | 365 | 35 | 9 | HP:0001763 | |
| HumanPheno | Broad long bones | 6.03e-04 | 157 | 35 | 6 | HP:0005622 | |
| HumanPheno | Sporadic | 6.15e-04 | 103 | 35 | 5 | HP:0003745 | |
| HumanPheno | Duane anomaly | 6.16e-04 | 25 | 35 | 3 | HP:0009921 | |
| HumanPheno | Shawl scrotum | 6.16e-04 | 25 | 35 | 3 | HP:0000049 | |
| HumanPheno | Incomitant strabismus | 6.16e-04 | 25 | 35 | 3 | HP:0025068 | |
| HumanPheno | Abnormal uterus morphology | 6.23e-04 | 158 | 35 | 6 | HP:0031105 | |
| HumanPheno | Abnormality of the philtrum | TGFB3 ZNF462 MAGEL2 ATG7 LMX1B NR4A2 SMARCA4 ANKRD17 SRRM2 CREBBP EP300 MEIS2 SCAF4 | 6.39e-04 | 726 | 35 | 13 | HP:0000288 |
| HumanPheno | Aplasia/Hypoplasia involving the musculature of the extremities | 6.76e-04 | 6 | 35 | 2 | HP:0009128 | |
| HumanPheno | Large foramen magnum | 6.76e-04 | 6 | 35 | 2 | HP:0002700 | |
| HumanPheno | Aplasia/Hypoplasia involving the musculature of the upper limbs | 6.76e-04 | 6 | 35 | 2 | HP:0001467 | |
| HumanPheno | Perimembranous ventricular septal defect | 6.93e-04 | 26 | 35 | 3 | HP:0011682 | |
| HumanPheno | Abnormality of upper lip vermillion | TGFB3 ZNF462 CACNA1A MAGEL2 SMARCA4 ANKRD17 SRRM2 CREBBP EP300 MEIS2 | 8.09e-04 | 464 | 35 | 10 | HP:0011339 |
| HumanPheno | Language impairment | ZNF462 CACNA1A MAGEL2 ATG7 ATXN2 LMX1B SOBP NR4A2 SMARCA4 ANKRD17 SRRM2 MN1 CREBBP VARS1 EP300 MEIS2 SCAF4 | 8.32e-04 | 1178 | 35 | 17 | HP:0002463 |
| HumanPheno | Dextrotransposition of the great arteries | 9.43e-04 | 7 | 35 | 2 | HP:0031348 | |
| HumanPheno | Deviated nasal septum | 9.43e-04 | 7 | 35 | 2 | HP:0004411 | |
| HumanPheno | Abnormal parietal bone morphology | 9.61e-04 | 29 | 35 | 3 | HP:0002696 | |
| HumanPheno | Abnormal upper lip morphology | TGFB3 ZNF462 CACNA1A MSX2 MAGEL2 ATG7 LMX1B NR4A2 SMARCA4 ANKRD17 SRRM2 CREBBP EP300 MEIS2 SCAF4 | 1.11e-03 | 980 | 35 | 15 | HP:0000177 |
| HumanPheno | Deviation of toes | 1.14e-03 | 118 | 35 | 5 | HP:0100498 | |
| HumanPheno | Bicuspid aortic valve | 1.18e-03 | 119 | 35 | 5 | HP:0001647 | |
| HumanPheno | Abnormality of the musculature of the thorax | 1.25e-03 | 8 | 35 | 2 | HP:0009131 | |
| HumanPheno | Abnormal pectoral muscle morphology | 1.25e-03 | 8 | 35 | 2 | HP:0011957 | |
| HumanPheno | Abnormal meningeal morphology | 1.27e-03 | 324 | 35 | 8 | HP:0010651 | |
| HumanPheno | Abnormal neural tube morphology | 1.27e-03 | 324 | 35 | 8 | HP:0410043 | |
| HumanPheno | Neural tube defect | 1.27e-03 | 324 | 35 | 8 | HP:0045005 | |
| HumanPheno | Abnormal aortic valve cusp morphology | 1.28e-03 | 121 | 35 | 5 | HP:0031567 | |
| HumanPheno | Tethered cord | 1.29e-03 | 32 | 35 | 3 | HP:0002144 | |
| HumanPheno | Congenital abnormal hair pattern | 1.35e-03 | 327 | 35 | 8 | HP:0011361 | |
| HumanPheno | Abnormal conus terminalis morphology | 1.41e-03 | 33 | 35 | 3 | HP:0031938 | |
| HumanPheno | Frontal upsweep of hair | 1.41e-03 | 33 | 35 | 3 | HP:0002236 | |
| HumanPheno | Aplasia of the toes | 1.53e-03 | 74 | 35 | 4 | HP:0011306 | |
| HumanPheno | Atypical scarring of skin | 1.53e-03 | 74 | 35 | 4 | HP:0000987 | |
| HumanPheno | Absent toe | 1.53e-03 | 74 | 35 | 4 | HP:0010760 | |
| HumanPheno | Aspiration | 1.54e-03 | 34 | 35 | 3 | HP:0002835 | |
| HumanPheno | Abnormality of temperature sensation | 1.54e-03 | 34 | 35 | 3 | HP:0100772 | |
| HumanPheno | Impaired temperature sensation | 1.54e-03 | 34 | 35 | 3 | HP:0010829 | |
| HumanPheno | Delayed speech and language development | ZNF462 CACNA1A MAGEL2 ATG7 LMX1B SOBP NR4A2 SMARCA4 ANKRD17 SRRM2 MN1 CREBBP VARS1 EP300 MEIS2 SCAF4 | 1.54e-03 | 1123 | 35 | 16 | HP:0000750 |
| HumanPheno | Genetic anticipation | 1.60e-03 | 9 | 35 | 2 | HP:0003743 | |
| HumanPheno | Pilomatrixoma | 1.60e-03 | 9 | 35 | 2 | HP:0030434 | |
| HumanPheno | Cervical cord compression | 1.60e-03 | 9 | 35 | 2 | HP:0002341 | |
| HumanPheno | Flared metaphysis | 1.68e-03 | 191 | 35 | 6 | HP:0003015 | |
| HumanPheno | Ventricular septal defect | TGFB3 ZNF462 SALL1 SMARCA4 SALL4 CREBBP EP300 MEIS2 SCAF4 ZIC3 | 1.69e-03 | 510 | 35 | 10 | HP:0001629 |
| MousePheno | abnormal embryonic growth/weight/body size | ZNF462 FOXO1 MSX2 TRIM33 BCL9L CASC3 NCOA6 ATG7 PRRC2C ANKRD17 SALL4 PRKCI REST HSD17B2 BCL9 SS18 MAP4K4 DENND1A CREBBP EP300 MEIS2 HDAC1 ZIC3 | 1.91e-08 | 1295 | 68 | 23 | MP:0002088 |
| MousePheno | embryonic growth retardation | FOXO1 MSX2 TRIM33 CASC3 NCOA6 ANKRD17 PRKCI REST HSD17B2 SS18 MAP4K4 DENND1A CREBBP EP300 MEIS2 HDAC1 ZIC3 | 9.23e-08 | 763 | 68 | 17 | MP:0003984 |
| MousePheno | abnormal prenatal growth/weight/body size | ZNF462 FOXO1 MSX2 TRIM33 BCL9L CASC3 NCOA6 ATG7 PRRC2C ANKRD17 SALL4 PRKCI REST HSD17B2 BCL9 SS18 MAP4K4 DENND1A CREBBP EP300 MEIS2 HDAC1 ZIC3 | 2.65e-07 | 1493 | 68 | 23 | MP:0004196 |
| MousePheno | prenatal growth retardation | FOXO1 MSX2 TRIM33 CASC3 NCOA6 ANKRD17 PRKCI REST HSD17B2 SS18 MAP4K4 DENND1A CREBBP EP300 MEIS2 HDAC1 ZIC3 | 5.87e-07 | 869 | 68 | 17 | MP:0010865 |
| MousePheno | embryonic lethality during organogenesis | FOXO1 BCL9L CASC3 NCOA6 SALL1 SMARCA4 ANKRD17 SMARCD3 SALL4 PRKCI REST HSD17B2 MAP4K4 DENND1A CREBBP EP300 HDAC1 | 6.57e-07 | 876 | 68 | 17 | MP:0006207 |
| MousePheno | abnormal embryo development | FOXO1 MSX2 TRIM33 BCL9L SRRT CASC3 NCOA6 LMX1B ANKRD17 SALL4 PRKCI REST HSD17B2 SS18 MAP4K4 DENND1A CREBBP EP300 MEIS2 HDAC1 ZIC3 | 1.15e-06 | 1370 | 68 | 21 | MP:0001672 |
| MousePheno | abnormal suckling behavior | 1.21e-06 | 113 | 68 | 7 | MP:0001436 | |
| MousePheno | exencephaly | 1.60e-06 | 230 | 68 | 9 | MP:0000914 | |
| MousePheno | abnormal embryonic tissue morphology | TGFB3 FOXO1 TRIM33 CASC3 LMX1B PRRC2C CECR2 SMARCC1 ANKRD17 SALL4 PRKCI REST SS18 MAP4K4 DENND1A CREBBP EP300 ZIC3 | 4.13e-06 | 1116 | 68 | 18 | MP:0002085 |
| MousePheno | abnormal extraembryonic tissue morphology | NCOA2 FOXO1 TRIM33 BCL9L NCOA6 CHERP ANKRD17 SALL4 PRKCI HSD17B2 SS18 DENND1A CREBBP EP300 HDAC1 ZIC3 | 5.26e-06 | 908 | 68 | 16 | MP:0002086 |
| MousePheno | abnormal nervous system development | CACNA1A MSX2 NCOA6 SALL1 LMX1B PRRC2C CECR2 NR4A2 SMARCA4 SMARCC1 ANKRD17 SALL4 REST HSD17B2 SS18 DENND1A CREBBP EP300 ZIC3 | 5.38e-06 | 1257 | 68 | 19 | MP:0003861 |
| MousePheno | embryonic lethality during organogenesis, complete penetrance | FOXO1 BCL9L CASC3 NCOA6 SMARCA4 ANKRD17 SMARCD3 PRKCI REST MAP4K4 DENND1A CREBBP EP300 HDAC1 | 5.44e-06 | 700 | 68 | 14 | MP:0011098 |
| MousePheno | absent triquetrum | 2.33e-05 | 2 | 68 | 2 | MP:0030862 | |
| MousePheno | thin myocardium | 5.70e-05 | 85 | 68 | 5 | MP:0002652 | |
| MousePheno | abnormal triquetrum morphology | 6.97e-05 | 3 | 68 | 2 | MP:0030861 | |
| MousePheno | abnormal head morphology | TGFB3 MSX2 NCOA6 ZFHX4 CECR2 MINK1 SMARCA4 SALL4 HSD17B2 MN1 CREBBP EP300 SEC23B TIPARP HDAC1 ZIC3 | 7.07e-05 | 1120 | 68 | 16 | MP:0000432 |
| MousePheno | thin myocardium compact layer | 7.16e-05 | 46 | 68 | 4 | MP:0004057 | |
| MousePheno | abnormal heart development | 7.48e-05 | 372 | 68 | 9 | MP:0000267 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | TGFB3 CACNA1A CASC3 FNDC3B NCOA6 SALL1 ZFHX4 ATG7 LMX1B NR4A2 SMARCD3 PRKCI MN1 CREBBP EP300 SEC23B MEIS2 | 8.91e-05 | 1269 | 68 | 17 | MP:0011111 |
| MousePheno | abnormal neural tube morphology | LMX1B PRRC2C CECR2 SMARCC1 ANKRD17 SALL4 SS18 DENND1A CREBBP EP300 ZIC3 | 1.20e-04 | 591 | 68 | 11 | MP:0002151 |
| MousePheno | facial bone hypoplasia | 1.67e-04 | 57 | 68 | 4 | MP:0030386 | |
| MousePheno | complete cleft palate | 2.31e-04 | 5 | 68 | 2 | MP:0021213 | |
| MousePheno | absent carpal bone | 2.31e-04 | 5 | 68 | 2 | MP:0000555 | |
| MousePheno | small premaxilla | 2.35e-04 | 25 | 68 | 3 | MP:0004870 | |
| MousePheno | embryonic growth arrest | 2.63e-04 | 346 | 68 | 8 | MP:0001730 | |
| MousePheno | perinatal lethality | TGFB3 CACNA1A FNDC3B NCOA6 MAGEL2 SALL1 ZFHX4 ATG7 LMX1B CECR2 NR4A2 MN1 CREBBP EP300 SEC23B | 2.80e-04 | 1130 | 68 | 15 | MP:0002081 |
| MousePheno | abnormal myocardium compact layer morphology | 3.12e-04 | 67 | 68 | 4 | MP:0004056 | |
| MousePheno | embryonic lethality during organogenesis, incomplete penetrance | 3.15e-04 | 268 | 68 | 7 | MP:0011108 | |
| MousePheno | abnormal anterior primitive streak morphology | 3.45e-04 | 6 | 68 | 2 | MP:0012739 | |
| MousePheno | abnormal supraoccipital bone morphology | 3.67e-04 | 29 | 68 | 3 | MP:0000078 | |
| MousePheno | abnormal facial morphology | TGFB3 MSX2 NCOA6 ZFHX4 CECR2 MINK1 SALL4 MN1 CREBBP EP300 SEC23B TIPARP ZIC3 | 3.82e-04 | 910 | 68 | 13 | MP:0003743 |
| MousePheno | ventricle myocardium hypoplasia | 3.89e-04 | 71 | 68 | 4 | MP:0010502 | |
| MousePheno | abnormal ear physiology | NCOA2 SALL1 TOX SOBP PRRC2C SLC26A5 TMCO6 SALL4 REST USH2A ZIC3 | 4.26e-04 | 684 | 68 | 11 | MP:0003878 |
| MousePheno | abnormal developmental patterning | TRIM33 CASC3 LMX1B SALL4 PRKCI SS18 MAP4K4 DENND1A EP300 ZIC3 | 4.45e-04 | 577 | 68 | 10 | MP:0002084 |
| MousePheno | abnormal mesoderm development | 4.56e-04 | 74 | 68 | 4 | MP:0001680 | |
| MousePheno | abnormal neural tube closure | 4.76e-04 | 378 | 68 | 8 | MP:0003720 | |
| MousePheno | abnormal R wave | 4.82e-04 | 7 | 68 | 2 | MP:0011919 | |
| MousePheno | abnormal frontal bone morphology | 5.31e-04 | 77 | 68 | 4 | MP:0000107 | |
| MousePheno | abnormal cerebellum vermis lobule morphology | 6.41e-04 | 8 | 68 | 2 | MP:0009957 | |
| MousePheno | absent organized vascular network | 6.41e-04 | 8 | 68 | 2 | MP:0000263 | |
| MousePheno | abnormal myocardial trabeculae morphology | 6.70e-04 | 144 | 68 | 5 | MP:0002189 | |
| MousePheno | abnormal craniofacial morphology | TGFB3 FOXO1 MSX2 NCOA6 ZFHX4 LMX1B CECR2 MINK1 SMARCA4 SALL4 MN1 CREBBP EP300 SEC23B TIPARP ZIC3 | 7.22e-04 | 1372 | 68 | 16 | MP:0000428 |
| MousePheno | craniofacial phenotype | TGFB3 FOXO1 MSX2 NCOA6 ZFHX4 LMX1B CECR2 MINK1 SMARCA4 SALL4 MN1 CREBBP EP300 SEC23B TIPARP ZIC3 | 7.22e-04 | 1372 | 68 | 16 | MP:0005382 |
| MousePheno | abnormal somite development | 7.22e-04 | 222 | 68 | 6 | MP:0001688 | |
| MousePheno | myocardium hypoplasia | 8.06e-04 | 86 | 68 | 4 | MP:0010500 | |
| MousePheno | abnormal brainstem morphology | 8.11e-04 | 227 | 68 | 6 | MP:0005277 | |
| MousePheno | abnormal cerebellum anterior vermis morphology | 8.21e-04 | 9 | 68 | 2 | MP:0000867 | |
| MousePheno | abnormal midbrain morphology | 8.30e-04 | 151 | 68 | 5 | MP:0000897 | |
| MousePheno | effusion | 8.55e-04 | 152 | 68 | 5 | MP:0021205 | |
| MousePheno | abnormal myocardium layer morphology | 8.64e-04 | 414 | 68 | 8 | MP:0005329 | |
| MousePheno | lethality during fetal growth through weaning, incomplete penetrance | CACNA1A NCOA6 MAGEL2 SALL1 SNAP91 LMX1B CECR2 SMARCA4 SALL4 HSD17B2 MN1 CREBBP EP300 ZIC3 | 8.76e-04 | 1124 | 68 | 14 | MP:0011112 |
| MousePheno | prenatal lethality, incomplete penetrance | NCOA6 MAGEL2 SALL1 ATXN2 SALL4 PRKCI HSD17B2 CREBBP EP300 HDAC1 ZIC3 | 8.87e-04 | 747 | 68 | 11 | MP:0011101 |
| MousePheno | oligodactyly | 8.88e-04 | 39 | 68 | 3 | MP:0000565 | |
| MousePheno | abnormal premaxilla morphology | 8.88e-04 | 39 | 68 | 3 | MP:0002820 | |
| MousePheno | abnormal palate morphology | 9.21e-04 | 321 | 68 | 7 | MP:0003755 | |
| MousePheno | abnormal brain development | CACNA1A MSX2 NCOA6 LMX1B NR4A2 SMARCC1 REST HSD17B2 DENND1A ZIC3 | 9.70e-04 | 638 | 68 | 10 | MP:0000913 |
| MousePheno | abnormal heart layer morphology | 9.78e-04 | 422 | 68 | 8 | MP:0010545 | |
| MousePheno | abnormal cerebellum anterior lobe morphology | 1.02e-03 | 10 | 68 | 2 | MP:0009960 | |
| MousePheno | cerebellum vermis hypoplasia | 1.02e-03 | 10 | 68 | 2 | MP:0000866 | |
| MousePheno | decreased palatine bone horizontal plate size | 1.02e-03 | 10 | 68 | 2 | MP:0009895 | |
| MousePheno | abnormal hearing physiology | 1.03e-03 | 643 | 68 | 10 | MP:0001963 | |
| MousePheno | abnormal secondary palate morphology | 1.05e-03 | 159 | 68 | 5 | MP:0013550 | |
| MousePheno | abnormal occipital bone morphology | 1.17e-03 | 95 | 68 | 4 | MP:0005269 | |
| MousePheno | absent cerebellum | 1.25e-03 | 11 | 68 | 2 | MP:0000850 | |
| MousePheno | hearing/vestibular/ear phenotype | NCOA2 MSX2 SALL1 TOX SOBP PRRC2C SLC26A5 TMCO6 SALL4 REST USH2A ZIC3 | 1.27e-03 | 905 | 68 | 12 | MP:0005377 |
| MousePheno | ventricular hypoplasia | 1.36e-03 | 99 | 68 | 4 | MP:0000279 | |
| MousePheno | abnormal dopaminergic neuron morphology | 1.44e-03 | 46 | 68 | 3 | MP:0003243 | |
| MousePheno | maxilla hypoplasia | 1.49e-03 | 12 | 68 | 2 | MP:0000457 | |
| MousePheno | abnormal oxygen level | 1.51e-03 | 256 | 68 | 6 | MP:0001574 | |
| MousePheno | neonatal lethality | TGFB3 CACNA1A FNDC3B NCOA6 SALL1 ZFHX4 ATG7 LMX1B NR4A2 MN1 SEC23B | 1.53e-03 | 799 | 68 | 11 | MP:0002058 |
| MousePheno | abnormal cardiovascular development | FOXO1 NCOA6 SMARCA4 ANKRD17 SMARCD3 SALL4 PRKCI CREBBP EP300 MEIS2 ZIC3 | 1.58e-03 | 802 | 68 | 11 | MP:0002925 |
| MousePheno | heart hypoplasia | 1.58e-03 | 103 | 68 | 4 | MP:0002740 | |
| MousePheno | abnormal interparietal bone morphology | 1.63e-03 | 48 | 68 | 3 | MP:0000077 | |
| MousePheno | ventricular septal defect | 1.66e-03 | 261 | 68 | 6 | MP:0010402 | |
| Domain | BROMODOMAIN_1 | 1.78e-08 | 37 | 87 | 6 | PS00633 | |
| Domain | BROMODOMAIN_2 | 3.38e-08 | 41 | 87 | 6 | PS50014 | |
| Domain | BROMO | 3.93e-08 | 42 | 87 | 6 | SM00297 | |
| Domain | Bromodomain | 3.93e-08 | 42 | 87 | 6 | IPR001487 | |
| Domain | - | 3.93e-08 | 42 | 87 | 6 | 1.20.920.10 | |
| Domain | Bromodomain | 8.68e-07 | 38 | 87 | 5 | PF00439 | |
| Domain | Nuc_rcpt_coact | 1.93e-06 | 6 | 87 | 3 | IPR009110 | |
| Domain | Bromodomain_CS | 6.07e-06 | 26 | 87 | 4 | IPR018359 | |
| Domain | CCDC74_C | 2.14e-05 | 2 | 87 | 2 | PF14917 | |
| Domain | BCL9_beta-catenin-bd_dom | 2.14e-05 | 2 | 87 | 2 | IPR024670 | |
| Domain | Nuc_rcpt_coact_CREBbp | 2.14e-05 | 2 | 87 | 2 | IPR014744 | |
| Domain | HAT_KAT11 | 2.14e-05 | 2 | 87 | 2 | PF08214 | |
| Domain | KIX | 2.14e-05 | 2 | 87 | 2 | PS50952 | |
| Domain | BCL9 | 2.14e-05 | 2 | 87 | 2 | PF11502 | |
| Domain | ZnF_TAZ | 2.14e-05 | 2 | 87 | 2 | SM00551 | |
| Domain | CBP_P300_HAT | 2.14e-05 | 2 | 87 | 2 | IPR031162 | |
| Domain | CCDC74 | 2.14e-05 | 2 | 87 | 2 | IPR033226 | |
| Domain | DUF902 | 2.14e-05 | 2 | 87 | 2 | PF06001 | |
| Domain | - | 2.14e-05 | 2 | 87 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 2.14e-05 | 2 | 87 | 2 | IPR010303 | |
| Domain | - | 2.14e-05 | 2 | 87 | 2 | 1.10.1630.10 | |
| Domain | Creb_binding | 2.14e-05 | 2 | 87 | 2 | PF09030 | |
| Domain | - | 2.14e-05 | 2 | 87 | 2 | 1.10.246.20 | |
| Domain | zf-TAZ | 2.14e-05 | 2 | 87 | 2 | PF02135 | |
| Domain | ZF_TAZ | 2.14e-05 | 2 | 87 | 2 | PS50134 | |
| Domain | CCDC74_C | 2.14e-05 | 2 | 87 | 2 | IPR029422 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 2.14e-05 | 2 | 87 | 2 | IPR013178 | |
| Domain | KAT11 | 2.14e-05 | 2 | 87 | 2 | SM01250 | |
| Domain | Znf_TAZ | 2.14e-05 | 2 | 87 | 2 | IPR000197 | |
| Domain | KIX_dom | 2.14e-05 | 2 | 87 | 2 | IPR003101 | |
| Domain | KIX | 2.14e-05 | 2 | 87 | 2 | PF02172 | |
| Domain | Bcl-9 | 2.14e-05 | 2 | 87 | 2 | IPR015668 | |
| Domain | CBP_P300_HAT | 2.14e-05 | 2 | 87 | 2 | PS51727 | |
| Domain | CNH | 3.42e-05 | 14 | 87 | 3 | SM00036 | |
| Domain | CNH | 4.27e-05 | 15 | 87 | 3 | PF00780 | |
| Domain | CNH | 4.27e-05 | 15 | 87 | 3 | PS50219 | |
| Domain | CNH_dom | 4.27e-05 | 15 | 87 | 3 | IPR001180 | |
| Domain | UDPGT | 1.22e-04 | 21 | 87 | 3 | PF00201 | |
| Domain | UDPGT | 1.22e-04 | 21 | 87 | 3 | PS00375 | |
| Domain | UDP_glucos_trans | 1.22e-04 | 21 | 87 | 3 | IPR002213 | |
| Domain | - | 2.35e-04 | 26 | 87 | 3 | 1.25.40.90 | |
| Domain | ENTH_VHS | 3.27e-04 | 29 | 87 | 3 | IPR008942 | |
| Domain | RNA_pol_II-bd | 4.44e-04 | 7 | 87 | 2 | IPR006903 | |
| Domain | CTD_bind | 4.44e-04 | 7 | 87 | 2 | PF04818 | |
| Domain | RPR | 5.90e-04 | 8 | 87 | 2 | SM00582 | |
| Domain | CID | 5.90e-04 | 8 | 87 | 2 | PS51391 | |
| Domain | CID_dom | 5.90e-04 | 8 | 87 | 2 | IPR006569 | |
| Domain | ZZ | 3.13e-03 | 18 | 87 | 2 | PF00569 | |
| Domain | ZF_ZZ_2 | 3.13e-03 | 18 | 87 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 3.13e-03 | 18 | 87 | 2 | PS01357 | |
| Domain | Zinc_finger_PHD-type_CS | 3.46e-03 | 65 | 87 | 3 | IPR019786 | |
| Domain | Znf_ZZ | 3.48e-03 | 19 | 87 | 2 | IPR000433 | |
| Domain | ZnF_ZZ | 3.48e-03 | 19 | 87 | 2 | SM00291 | |
| Domain | zf-C2H2 | 4.93e-03 | 693 | 87 | 9 | PF00096 | |
| Domain | Znf_C2H2/integrase_DNA-bd | 4.97e-03 | 694 | 87 | 9 | IPR013087 | |
| Domain | G_patch | 5.09e-03 | 23 | 87 | 2 | SM00443 | |
| Domain | G_patch_dom | 5.09e-03 | 23 | 87 | 2 | IPR000467 | |
| Domain | G_PATCH | 5.09e-03 | 23 | 87 | 2 | PS50174 | |
| Domain | G-patch | 5.09e-03 | 23 | 87 | 2 | PF01585 | |
| Domain | PHD | 5.18e-03 | 75 | 87 | 3 | PF00628 | |
| Domain | Znf_PHD-finger | 5.98e-03 | 79 | 87 | 3 | IPR019787 | |
| Domain | ZnF_U1 | 8.03e-03 | 29 | 87 | 2 | SM00451 | |
| Domain | Znf_U1 | 8.03e-03 | 29 | 87 | 2 | IPR003604 | |
| Domain | PHD | 8.31e-03 | 89 | 87 | 3 | SM00249 | |
| Domain | Znf_PHD | 8.83e-03 | 91 | 87 | 3 | IPR001965 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 7.43e-09 | 18 | 57 | 5 | M26942 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | TRIM33 SALL1 SMARCA4 SMARCC1 SALL4 REST ZNF281 CREBBP EP300 HDAC1 ZIC3 | 2.70e-08 | 301 | 57 | 11 | MM15983 |
| Pathway | BIOCARTA_VDR_PATHWAY | 3.62e-08 | 24 | 57 | 5 | M13404 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 5.57e-08 | 26 | 57 | 5 | MM14793 | |
| Pathway | PID_AR_TF_PATHWAY | 6.61e-08 | 53 | 57 | 6 | M151 | |
| Pathway | PID_BETA_CATENIN_NUC_PATHWAY | 7.96e-07 | 80 | 57 | 6 | M223 | |
| Pathway | PID_REG_GR_PATHWAY | 9.22e-07 | 82 | 57 | 6 | M115 | |
| Pathway | REACTOME_HEME_SIGNALING | 1.50e-06 | 49 | 57 | 5 | M41832 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 1.66e-06 | 22 | 57 | 4 | MM1370 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 1.71e-06 | 91 | 57 | 6 | M27101 | |
| Pathway | REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION | 3.93e-06 | 27 | 57 | 4 | M26943 | |
| Pathway | REACTOME_ADIPOGENESIS | 5.17e-06 | 110 | 57 | 6 | M48259 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 5.29e-06 | 29 | 57 | 4 | M48076 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 6.09e-06 | 30 | 57 | 4 | M207 | |
| Pathway | WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY | 6.97e-06 | 31 | 57 | 4 | M39476 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 7.37e-06 | 10 | 57 | 3 | M27945 | |
| Pathway | REACTOME_CIRCADIAN_CLOCK | 8.95e-06 | 70 | 57 | 5 | M938 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 1.02e-05 | 34 | 57 | 4 | MM15531 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 1.26e-05 | 272 | 57 | 8 | M29619 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 1.44e-05 | 37 | 57 | 4 | M27797 | |
| Pathway | REACTOME_POU5F1_OCT4_SOX2_NANOG_ACTIVATE_GENES_RELATED_TO_PROLIFERATION | 1.74e-05 | 13 | 57 | 3 | M27209 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 1.82e-05 | 137 | 57 | 6 | M48232 | |
| Pathway | PID_SMAD2_3NUCLEAR_PATHWAY | 1.94e-05 | 82 | 57 | 5 | M2 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 2.19e-05 | 84 | 57 | 5 | M1008 | |
| Pathway | WP_ENDODERM_DIFFERENTIATION | 2.33e-05 | 143 | 57 | 6 | M39591 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION | 2.40e-05 | 42 | 57 | 4 | M48237 | |
| Pathway | REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP | 2.40e-05 | 42 | 57 | 4 | M27172 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 2.76e-05 | 15 | 57 | 3 | MM15697 | |
| Pathway | WP_ANDROGEN_RECEPTOR_SIGNALING | 3.22e-05 | 91 | 57 | 5 | M39700 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 3.38e-05 | 16 | 57 | 3 | M8516 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES | 3.38e-05 | 16 | 57 | 3 | M27940 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 3.97e-05 | 95 | 57 | 5 | M48268 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 4.09e-05 | 17 | 57 | 3 | MM1509 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS | 4.39e-05 | 97 | 57 | 5 | M48262 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 5.80e-05 | 19 | 57 | 3 | M18933 | |
| Pathway | REACTOME_HEME_DEGRADATION | 6.80e-05 | 20 | 57 | 3 | MM14721 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 6.96e-05 | 254 | 57 | 7 | M27131 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS | 7.03e-05 | 55 | 57 | 4 | M27145 | |
| Pathway | REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF | 7.03e-05 | 55 | 57 | 4 | M27001 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 7.03e-05 | 55 | 57 | 4 | M14933 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 7.21e-05 | 175 | 57 | 6 | MM14941 | |
| Pathway | WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX | 7.92e-05 | 21 | 57 | 3 | M39593 | |
| Pathway | REACTOME_CYTOPROTECTION_BY_HMOX1 | 9.90e-05 | 60 | 57 | 4 | M41830 | |
| Pathway | REACTOME_PREDNISONE_ADME | 1.05e-04 | 23 | 57 | 3 | MM16639 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 1.12e-04 | 118 | 57 | 5 | M27316 | |
| Pathway | REACTOME_GLUCURONIDATION | 1.19e-04 | 24 | 57 | 3 | MM14599 | |
| Pathway | REACTOME_GLUCURONIDATION | 1.35e-04 | 25 | 57 | 3 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 1.35e-04 | 25 | 57 | 3 | MM15820 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 1.35e-04 | 25 | 57 | 3 | M605 | |
| Pathway | PID_RB_1PATHWAY | 1.35e-04 | 65 | 57 | 4 | M279 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION | 1.44e-04 | 66 | 57 | 4 | M27938 | |
| Pathway | BIOCARTA_CARM_ER_PATHWAY | 1.53e-04 | 26 | 57 | 3 | M2499 | |
| Pathway | PID_HDAC_CLASSIII_PATHWAY | 1.53e-04 | 26 | 57 | 3 | M32 | |
| Pathway | WP_GLUCURONIDATION | 1.53e-04 | 26 | 57 | 3 | M39404 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 1.59e-04 | 5 | 57 | 2 | MM1575 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 1.59e-04 | 5 | 57 | 2 | M48020 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 1.59e-04 | 5 | 57 | 2 | M48023 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 1.59e-04 | 5 | 57 | 2 | M27228 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 1.91e-04 | 28 | 57 | 3 | M19580 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_CHEMICAL_STRESS | 1.96e-04 | 210 | 57 | 6 | M41836 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 2.38e-04 | 6 | 57 | 2 | M22062 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 2.38e-04 | 6 | 57 | 2 | MM15660 | |
| Pathway | WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1 | 2.60e-04 | 31 | 57 | 3 | M39522 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_PLURIPOTENT_STEM_CELLS | 2.60e-04 | 31 | 57 | 3 | M27393 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | 2.66e-04 | 142 | 57 | 5 | M48257 | |
| Pathway | WP_PREGNANE_X_RECEPTOR_PATHWAY | 2.86e-04 | 32 | 57 | 3 | M39567 | |
| Pathway | WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR | 2.86e-04 | 32 | 57 | 3 | M39521 | |
| Pathway | REACTOME_METABOLISM_OF_PORPHYRINS | 2.86e-04 | 32 | 57 | 3 | MM14719 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | FOXO1 MSX2 TRIM33 SRRT CASC3 WDR33 POLDIP3 NR4A2 SMARCA4 SMARCC1 SMARCD3 REST CREBBP EP300 HDAC1 | 2.99e-04 | 1387 | 57 | 15 | M734 |
| Pathway | WP_VEGFAVEGFR2_SIGNALING | 3.18e-04 | 431 | 57 | 8 | M39729 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 3.32e-04 | 149 | 57 | 5 | M27888 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 3.33e-04 | 7 | 57 | 2 | MM1573 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_REST_MEDIATED_TRANSCRIPTIONAL_REPRESSION | 3.33e-04 | 7 | 57 | 2 | M47673 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 3.43e-04 | 233 | 57 | 6 | M27099 | |
| Pathway | WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA | 3.43e-04 | 34 | 57 | 3 | M39771 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 3.74e-04 | 35 | 57 | 3 | M47969 | |
| Pathway | WP_MESODERMAL_COMMITMENT_PATHWAY | 3.75e-04 | 153 | 57 | 5 | M39546 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 3.75e-04 | 153 | 57 | 5 | MM15522 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 3.76e-04 | 237 | 57 | 6 | M27786 | |
| Pathway | REACTOME_METABOLISM_OF_STEROIDS | 3.86e-04 | 154 | 57 | 5 | M27832 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | NCOA2 FOXO1 TRIM33 CASC3 NCOA6 SALL1 SMARCA4 SMARCC1 SMARCD3 SALL4 SS18 CREBBP EP300 HDAC1 ZIC3 | 4.22e-04 | 1432 | 57 | 15 | M509 |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 4.34e-04 | 158 | 57 | 5 | MM14791 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 4.43e-04 | 8 | 57 | 2 | M22058 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 4.43e-04 | 8 | 57 | 2 | M48022 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 4.43e-04 | 8 | 57 | 2 | M48024 | |
| Pathway | REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES | 4.43e-04 | 8 | 57 | 2 | M46443 | |
| Pathway | WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS | 4.47e-04 | 159 | 57 | 5 | M39373 | |
| Pathway | WP_INSULIN_SIGNALING | 4.60e-04 | 160 | 57 | 5 | MM15956 | |
| Pathway | WP_INSULIN_SIGNALING | 4.60e-04 | 160 | 57 | 5 | M39482 | |
| Pathway | REACTOME_RMTS_METHYLATE_HISTONE_ARGININES | 5.57e-04 | 40 | 57 | 3 | MM14936 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 5.59e-04 | 94 | 57 | 4 | M1041 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY | 5.68e-04 | 9 | 57 | 2 | M47451 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 5.99e-04 | 41 | 57 | 3 | M7399 | |
| Pathway | REACTOME_MITOCHONDRIAL_BIOGENESIS | 6.05e-04 | 96 | 57 | 4 | M26973 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 6.43e-04 | 42 | 57 | 3 | M17541 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 6.43e-04 | 42 | 57 | 3 | M27272 | |
| Pathway | WP_IL6_SIGNALING_PATHWAY | 7.06e-04 | 100 | 57 | 4 | MM15826 | |
| Pathway | BIOCARTA_HSWI_SNF_PATHWAY | 7.08e-04 | 10 | 57 | 2 | MM1532 | |
| Pathway | REACTOME_ASPIRIN_ADME | 7.38e-04 | 44 | 57 | 3 | M45014 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 7.38e-04 | 44 | 57 | 3 | M27295 | |
| Pubmed | KIAA1671 NCOA2 ZNF462 TRIM33 BCL9L SRRT NCOA6 SALL1 ZFHX4 ATXN2 WDR33 SOBP POLDIP3 PRRC2C SMARCA4 SMARCC1 ANKRD17 SMARCD3 SSBP4 BCL9 SRRM2 ZNF281 SS18 CREBBP RBM20 EP300 SEC23B SCAF4 ZIC3 | 6.94e-19 | 1429 | 88 | 29 | 35140242 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | KIAA1671 NCOA2 ZNF462 TRIM33 BCL9L NCOA6 SALL1 ZFHX4 SOBP SMARCA4 SMARCC1 SMARCD3 BCL9 ZNF281 CREBBP EP300 HDAC1 | 2.54e-17 | 351 | 88 | 17 | 38297188 |
| Pubmed | Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex. | 1.93e-12 | 7 | 88 | 5 | 9590696 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | ZNF462 TRIM33 SRRT SALL1 POLDIP3 SMARCA4 SMARCC1 SALL4 SRRM2 ZNF281 SS18 EP300 MEIS2 HDAC1 | 2.42e-12 | 411 | 88 | 14 | 35182466 |
| Pubmed | NCOA2 TRIM33 BCL9L NCOA6 CHERP WDR33 PHF3 SMARCA4 SMARCC1 BCL9 ZNF281 CREBBP | 4.18e-12 | 268 | 88 | 12 | 33640491 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | NCOA2 TRIM33 BCL9L FNDC3B NCOA6 ATXN2 WDR33 PRRC2C SMARCC1 ANKRD17 BCL9 CREBBP RBM20 EP300 | 9.96e-12 | 457 | 88 | 14 | 32344865 |
| Pubmed | KIAA1671 TRIM33 ZNF469 ZFHX4 CECR2 PNMA2 GPATCH2 SMARCA4 SMARCC1 ANKRD17 SMARCD3 SRRM2 SP110 ZNF281 SS18 CREBBP ENKD1 EP300 HDAC1 | 3.94e-11 | 1116 | 88 | 19 | 31753913 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | KIAA1671 FOXO1 SRRT CASC3 SYNRG NCOA6 PHF3 PRRC2C MINK1 ANKRD17 ARHGAP17 PRKCI SRRM2 MAP4K4 DENND1A ENKD1 SEC23B | 5.00e-11 | 861 | 88 | 17 | 36931259 |
| Pubmed | KIAA1671 NCOA2 SYNRG NCOA6 WDR33 PHF3 PRRC2C SMARCA4 SMARCC1 MAP4K4 CREBBP EP300 HDAC1 SCAF4 | 1.12e-10 | 549 | 88 | 14 | 38280479 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | TRIM33 SRRT NCOA6 SALL1 CHERP SNAP91 ATXN2 WDR33 PHF3 POLDIP3 PRRC2C SMARCA4 SMARCC1 SRRM2 ZNF281 SS18 SCAF4 | 2.42e-10 | 954 | 88 | 17 | 36373674 |
| Pubmed | 2.60e-10 | 157 | 88 | 9 | 30186101 | ||
| Pubmed | 8.99e-10 | 75 | 88 | 7 | 25593309 | ||
| Pubmed | 1.39e-09 | 20 | 88 | 5 | 11877444 | ||
| Pubmed | 1.85e-09 | 83 | 88 | 7 | 28794006 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | NCOA2 TRIM33 SALL1 ZFHX4 CECR2 PNMA2 SMARCA4 SMARCC1 CREBBP RBM20 EP300 | 5.59e-09 | 398 | 88 | 11 | 35016035 |
| Pubmed | Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway. | 7.94e-09 | 10 | 88 | 4 | 16751102 | |
| Pubmed | REST repression of neuronal genes requires components of the hSWI.SNF complex. | 8.68e-09 | 28 | 88 | 5 | 12192000 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SRRT SYNRG NCOA6 PHF3 MINK1 SMARCA4 SMARCC1 ANKRD17 REST BCL9 SRRM2 MAP4K4 MN1 SCAF4 | 9.15e-09 | 774 | 88 | 14 | 15302935 |
| Pubmed | TRIM33 BCL9L SRRT CASC3 NCOA6 CECR2 SMARCC1 ARHGAP17 BCL9 CREBBP EP300 | 1.10e-08 | 425 | 88 | 11 | 24999758 | |
| Pubmed | Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. | 1.25e-08 | 11 | 88 | 4 | 10204490 | |
| Pubmed | 1.25e-08 | 11 | 88 | 4 | 18003620 | ||
| Pubmed | Cooperation of the transcriptional coactivators CBP and p300 with Stat6. | 1.57e-08 | 3 | 88 | 3 | 10454341 | |
| Pubmed | NCOA2 TRIM33 NCOA6 ATXN2 POLDIP3 PRRC2C SMARCA4 SMARCC1 BCL9 SRRM2 ZNF281 CREBBP VARS1 EP300 HDAC1 SCAF4 | 1.60e-08 | 1103 | 88 | 16 | 34189442 | |
| Pubmed | 2.43e-08 | 34 | 88 | 5 | 30894540 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | KIAA1671 NCOA2 FOXO1 TRIM33 SYNRG SALL1 WDR33 POLDIP3 PRRC2C ARHGAP17 CREBBP RBM20 | 3.12e-08 | 588 | 88 | 12 | 38580884 |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 5.06e-08 | 203 | 88 | 8 | 22083510 | |
| Pubmed | 5.11e-08 | 15 | 88 | 4 | 23785148 | ||
| Pubmed | Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1. | 5.67e-08 | 40 | 88 | 5 | 34585037 | |
| Pubmed | Msx3 protein recruits histone deacetylase to down-regulate the Msx1 promoter. | 6.25e-08 | 4 | 88 | 3 | 11115394 | |
| Pubmed | A protein interaction network for pluripotency of embryonic stem cells. | 6.45e-08 | 41 | 88 | 5 | 17093407 | |
| Pubmed | Targeting USP9X-AMPK Axis in ARID1A-Deficient Hepatocellular Carcinoma. | 6.80e-08 | 16 | 88 | 4 | 35390516 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | ZNF462 SRRT CHERP WDR33 POLDIP3 CECR2 SMARCA4 SMARCC1 SMARCD3 SRRM2 ZNF281 MAP4K4 VARS1 SEC23B SCAF4 | 8.55e-08 | 1082 | 88 | 15 | 38697112 |
| Pubmed | 8.88e-08 | 17 | 88 | 4 | 19183483 | ||
| Pubmed | TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation. | 1.14e-07 | 18 | 88 | 4 | 28068325 | |
| Pubmed | An expanded Oct4 interaction network: implications for stem cell biology, development, and disease. | 1.24e-07 | 91 | 88 | 6 | 20362542 | |
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 1.31e-07 | 153 | 88 | 7 | 26365490 | |
| Pubmed | NCOA2 ZNF462 CACNA1A CASC3 SNAP91 ATXN2 PRRC2C MINK1 SMARCA4 SMARCC1 ANKRD17 PRKCI BCL9 MAP4K4 | 1.36e-07 | 963 | 88 | 14 | 28671696 | |
| Pubmed | 1.56e-07 | 5 | 88 | 3 | 11003650 | ||
| Pubmed | 1.56e-07 | 5 | 88 | 3 | 16645043 | ||
| Pubmed | 1.56e-07 | 5 | 88 | 3 | 14966121 | ||
| Pubmed | The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. | 1.56e-07 | 5 | 88 | 3 | 11931769 | |
| Pubmed | Regulation of murine TGFbeta2 by Pax3 during early embryonic development. | 1.56e-07 | 5 | 88 | 3 | 16787918 | |
| Pubmed | 1.56e-07 | 5 | 88 | 3 | 11912212 | ||
| Pubmed | 1.56e-07 | 5 | 88 | 3 | 16291753 | ||
| Pubmed | 1.56e-07 | 5 | 88 | 3 | 19448667 | ||
| Pubmed | 1.98e-07 | 51 | 88 | 5 | 22770845 | ||
| Pubmed | 2.05e-07 | 99 | 88 | 6 | 34161765 | ||
| Pubmed | 2.22e-07 | 21 | 88 | 4 | 19596656 | ||
| Pubmed | NCOA2 ZNF462 FOXO1 MSX2 TOX NR4A2 SMARCA4 SMARCC1 KLF17 REST CREBBP MEIS2 | 2.35e-07 | 709 | 88 | 12 | 22988430 | |
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 2.38e-07 | 167 | 88 | 7 | 20362541 | |
| Pubmed | Sox2 cooperates with Chd7 to regulate genes that are mutated in human syndromes. | 2.41e-07 | 53 | 88 | 5 | 21532573 | |
| Pubmed | 2.59e-07 | 103 | 88 | 6 | 32744500 | ||
| Pubmed | A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf-Hirschhorn syndrome. | 2.70e-07 | 22 | 88 | 4 | 19483677 | |
| Pubmed | UHRF1 inhibits MDR1 gene transcription and sensitizes breast cancer cells to anticancer drugs. | 3.11e-07 | 6 | 88 | 3 | 20037778 | |
| Pubmed | 3.11e-07 | 6 | 88 | 3 | 15731352 | ||
| Pubmed | CBP-mediated FOXO-1 acetylation inhibits pancreatic tumor growth by targeting SirT. | 3.11e-07 | 6 | 88 | 3 | 24419059 | |
| Pubmed | 3.11e-07 | 6 | 88 | 3 | 26123998 | ||
| Pubmed | Transforming activity of MECT1-MAML2 fusion oncoprotein is mediated by constitutive CREB activation. | 3.11e-07 | 6 | 88 | 3 | 15961999 | |
| Pubmed | 3.11e-07 | 6 | 88 | 3 | 10973497 | ||
| Pubmed | Stat3 dimerization regulated by reversible acetylation of a single lysine residue. | 3.11e-07 | 6 | 88 | 3 | 15653507 | |
| Pubmed | 3.11e-07 | 6 | 88 | 3 | 16734381 | ||
| Pubmed | 3.11e-07 | 6 | 88 | 3 | 32494626 | ||
| Pubmed | ZNF462 TRIM33 BCL9L PRRC2C CECR2 SMARCA4 SMARCC1 SALL4 REST ZNF281 | 3.19e-07 | 469 | 88 | 10 | 27634302 | |
| Pubmed | FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex. | 3.27e-07 | 23 | 88 | 4 | 30962207 | |
| Pubmed | Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation. | 3.95e-07 | 180 | 88 | 7 | 30110629 | |
| Pubmed | Human ING1 proteins differentially regulate histone acetylation. | 5.44e-07 | 7 | 88 | 3 | 12015309 | |
| Pubmed | A switch from hBrm to Brg1 at IFNγ-activated sequences mediates the activation of human genes. | 5.44e-07 | 7 | 88 | 3 | 21079652 | |
| Pubmed | 5.44e-07 | 7 | 88 | 3 | 23540691 | ||
| Pubmed | 5.44e-07 | 7 | 88 | 3 | 17074803 | ||
| Pubmed | 5.44e-07 | 7 | 88 | 3 | 28369036 | ||
| Pubmed | TIF1beta regulates the pluripotency of embryonic stem cells in a phosphorylation-dependent manner. | 5.44e-07 | 7 | 88 | 3 | 20508149 | |
| Pubmed | The SWI/SNF chromatin-remodeling complex is a cofactor for Tat transactivation of the HIV promoter. | 5.44e-07 | 7 | 88 | 3 | 16687403 | |
| Pubmed | Pokemon (FBI-1) interacts with Smad4 to repress TGF-β-induced transcriptional responses. | 5.44e-07 | 7 | 88 | 3 | 25514493 | |
| Pubmed | 5.48e-07 | 26 | 88 | 4 | 10778858 | ||
| Pubmed | 6.42e-07 | 27 | 88 | 4 | 29374058 | ||
| Pubmed | 7.32e-07 | 66 | 88 | 5 | 23275444 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SRRT NCOA6 CHERP WDR33 PHF3 POLDIP3 SMARCA4 SMARCC1 REST SRRM2 SP110 ZNF281 EP300 HDAC1 SCAF4 | 8.30e-07 | 1294 | 88 | 15 | 30804502 |
| Pubmed | 8.66e-07 | 29 | 88 | 4 | 19279220 | ||
| Pubmed | 8.69e-07 | 8 | 88 | 3 | 20935208 | ||
| Pubmed | Activation of Smad transcriptional activity by protein inhibitor of activated STAT3 (PIAS3). | 8.69e-07 | 8 | 88 | 3 | 14691252 | |
| Pubmed | 8.69e-07 | 8 | 88 | 3 | 10490106 | ||
| Pubmed | 1.30e-06 | 9 | 88 | 3 | 22511988 | ||
| Pubmed | 1.30e-06 | 9 | 88 | 3 | 1339448 | ||
| Pubmed | 1.30e-06 | 9 | 88 | 3 | 18241125 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 1.50e-06 | 430 | 88 | 9 | 35044719 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 1.51e-06 | 220 | 88 | 7 | 35785414 | |
| Pubmed | A global genomic transcriptional code associated with CNS-expressed genes. | 1.52e-06 | 318 | 88 | 8 | 16919269 | |
| Pubmed | 1.61e-06 | 222 | 88 | 7 | 37071664 | ||
| Pubmed | Dopaminergic control of autophagic-lysosomal function implicates Lmx1b in Parkinson's disease. | 1.67e-06 | 34 | 88 | 4 | 25915474 | |
| Pubmed | SRRT CASC3 ATXN2 WDR33 PHF3 POLDIP3 PRRC2C GPATCH2 SMARCA4 SMARCC1 ANKRD17 PRKCI DENND1A VARS1 SCAF4 | 1.70e-06 | 1371 | 88 | 15 | 36244648 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | NCOA2 FOXO1 TRIM33 SALL1 ZFHX4 PRRC2C SMARCA4 SMARCC1 ANKRD17 CREBBP VARS1 EP300 | 1.71e-06 | 857 | 88 | 12 | 25609649 |
| Pubmed | 1.85e-06 | 10 | 88 | 3 | 23642732 | ||
| Pubmed | 1.85e-06 | 10 | 88 | 3 | 18765668 | ||
| Pubmed | 1.85e-06 | 10 | 88 | 3 | 19061646 | ||
| Pubmed | 1.85e-06 | 10 | 88 | 3 | 34716243 | ||
| Pubmed | 1.85e-06 | 10 | 88 | 3 | 25314079 | ||
| Pubmed | 1.85e-06 | 10 | 88 | 3 | 11465080 | ||
| Pubmed | Purification and characterization of mSin3A-containing Brg1 and hBrm chromatin remodeling complexes. | 1.85e-06 | 10 | 88 | 3 | 11238380 | |
| Pubmed | 1.85e-06 | 10 | 88 | 3 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 1.85e-06 | 10 | 88 | 3 | 22558097 | |
| Interaction | SP7 interactions | NCOA2 TRIM33 BCL9L SRRT NCOA6 ZFHX4 WDR33 SMARCA4 SMARCC1 SMARCD3 BCL9 ZNF281 SS18 CREBBP RBM20 EP300 SCAF4 | 1.62e-14 | 304 | 88 | 17 | int:SP7 |
| Interaction | SOX7 interactions | NCOA2 TRIM33 SALL1 ZFHX4 CECR2 SMARCA4 SMARCC1 CREBBP RBM20 EP300 | 2.46e-12 | 82 | 88 | 10 | int:SOX7 |
| Interaction | TLE3 interactions | NCOA2 BCL9L SRRT SALL1 CHERP CECR2 SMARCA4 SSBP4 BCL9 SRRM2 ZNF281 CREBBP RBM20 EP300 HDAC1 SCAF4 | 6.70e-12 | 376 | 88 | 16 | int:TLE3 |
| Interaction | EGR2 interactions | NCOA2 ZNF462 TRIM33 BCL9L NCOA6 ZFHX4 SMARCC1 SMARCD3 BCL9 ZNF281 CREBBP EP300 | 1.11e-11 | 171 | 88 | 12 | int:EGR2 |
| Interaction | TBXT interactions | NCOA2 NCOA6 ZFHX4 SMARCA4 SMARCC1 BCL9 ZNF281 SS18 CREBBP EP300 | 8.34e-11 | 116 | 88 | 10 | int:TBXT |
| Interaction | SMARCA4 interactions | FOXO1 TRIM33 ATG7 NR4A2 SMARCA4 SMARCC1 SMARCD3 SALL4 REST SRRM2 SS18 CREBBP EP300 TIPARP HDAC1 STAT6 | 1.43e-10 | 462 | 88 | 16 | int:SMARCA4 |
| Interaction | ERG interactions | NCOA2 TRIM33 NCOA6 ZFHX4 SMARCA4 SMARCC1 SMARCD3 BCL9 ZNF281 SS18 CREBBP EP300 | 2.46e-10 | 223 | 88 | 12 | int:ERG |
| Interaction | NCOA1 interactions | NCOA2 FOXO1 NCOA6 NR4A2 SMARCA4 SMARCC1 CREBBP EP300 TIPARP STAT6 | 8.13e-10 | 146 | 88 | 10 | int:NCOA1 |
| Interaction | MYOD1 interactions | NCOA2 TRIM33 SMARCA4 SMARCC1 SMARCD3 BCL9 ZNF281 SS18 CREBBP EP300 HDAC1 | 8.31e-10 | 194 | 88 | 11 | int:MYOD1 |
| Interaction | FOS interactions | NCOA2 TRIM33 NCOA6 SMARCA4 SMARCC1 ANKRD17 SMARCD3 BCL9 SS18 CREBBP VARS1 ENKD1 EP300 | 9.70e-10 | 312 | 88 | 13 | int:FOS |
| Interaction | GATA2 interactions | MSX2 NCOA6 SALL1 ZFHX4 SMARCA4 SMARCC1 BCL9 ZNF281 SS18 CREBBP EP300 | 1.09e-09 | 199 | 88 | 11 | int:GATA2 |
| Interaction | CRX interactions | NCOA2 ZNF462 TRIM33 BCL9L SALL1 ZFHX4 SMARCC1 SMARCD3 PRKCI BCL9 CREBBP EP300 | 1.09e-09 | 254 | 88 | 12 | int:CRX |
| Interaction | HNF4A interactions | NCOA2 ZNF462 FOXO1 TRIM33 NCOA6 SMARCA4 SMARCC1 SMARCD3 ZNF281 SS18 CREBBP EP300 | 2.68e-09 | 275 | 88 | 12 | int:HNF4A |
| Interaction | NUP35 interactions | NCOA2 TRIM33 BCL9L FNDC3B NCOA6 ATXN2 WDR33 PRRC2C SMARCC1 ANKRD17 BCL9 CREBBP RBM20 EP300 | 4.20e-09 | 424 | 88 | 14 | int:NUP35 |
| Interaction | GSC interactions | 4.22e-09 | 87 | 88 | 8 | int:GSC | |
| Interaction | TPRX2 interactions | 4.63e-09 | 56 | 88 | 7 | int:TPRX2 | |
| Interaction | TLX1 interactions | NCOA2 ZNF462 SALL1 ZFHX4 SMARCC1 BCL9 ZNF281 CREBBP EP300 MEIS2 | 4.74e-09 | 175 | 88 | 10 | int:TLX1 |
| Interaction | SOX17 interactions | 8.52e-09 | 95 | 88 | 8 | int:SOX17 | |
| Interaction | PPARG interactions | NCOA2 FOXO1 MSX2 NCOA6 NR4A2 SMARCA4 SMARCC1 SMARCD3 CREBBP EP300 HDAC1 STAT6 | 9.21e-09 | 307 | 88 | 12 | int:PPARG |
| Interaction | KLF5 interactions | NCOA2 NCOA6 POLDIP3 BCL9 ZNF281 SS18 CREBBP RBM20 EP300 HDAC1 | 1.34e-08 | 195 | 88 | 10 | int:KLF5 |
| Interaction | GATA4 interactions | ZNF462 SRRT SALL1 POLDIP3 SMARCA4 SMARCC1 SMARCD3 SALL4 SRRM2 ZNF281 SS18 EP300 HDAC1 | 2.63e-08 | 411 | 88 | 13 | int:GATA4 |
| Interaction | AR interactions | NCOA2 ZNF462 FOXO1 TRIM33 BCL9L SRRT NCOA6 CHERP WDR33 PHF3 SMARCA4 SMARCC1 BCL9 ZNF281 CREBBP EP300 SEC23B TIPARP HDAC1 | 4.22e-08 | 992 | 88 | 19 | int:AR |
| Interaction | YWHAH interactions | KIAA1671 NCOA2 FOXO1 SRRT CASC3 SYNRG NCOA6 KANK1 PHF3 PRRC2C MINK1 ANKRD17 ARHGAP17 PRKCI SRRM2 MAP4K4 DENND1A CREBBP ENKD1 SEC23B | 4.23e-08 | 1102 | 88 | 20 | int:YWHAH |
| Interaction | PAX6 interactions | ZNF462 NCOA6 SALL1 ZFHX4 SMARCA4 SMARCC1 SMARCD3 BCL9 ZNF281 CREBBP EP300 MEIS2 | 6.39e-08 | 366 | 88 | 12 | int:PAX6 |
| Interaction | PAX7 interactions | 6.97e-08 | 124 | 88 | 8 | int:PAX7 | |
| Interaction | PBX1 interactions | 8.90e-08 | 85 | 88 | 7 | int:PBX1 | |
| Interaction | EP300 interactions | NCOA2 FOXO1 SRRT CASC3 NCOA6 ZNF469 ATG7 POLDIP3 SMARCA4 SMARCC1 SSBP4 SRRM2 SS18 MN1 CREBBP VARS1 EP300 SEC23B TIPARP HDAC1 SCAF4 STAT6 | 1.01e-07 | 1401 | 88 | 22 | int:EP300 |
| Interaction | SMARCC1 interactions | MSX2 TRIM33 SMARCA4 SMARCC1 SMARCD3 SALL4 SRRM2 SS18 CREBBP EP300 TIPARP HDAC1 | 1.08e-07 | 384 | 88 | 12 | int:SMARCC1 |
| Interaction | GATA3 interactions | 1.28e-07 | 187 | 88 | 9 | int:GATA3 | |
| Interaction | HNF1B interactions | 1.46e-07 | 190 | 88 | 9 | int:HNF1B | |
| Interaction | NANOG interactions | ZNF462 TRIM33 SALL1 CHERP WDR33 CECR2 SMARCA4 SALL4 REST ZNF281 EP300 HDAC1 ZIC3 | 1.63e-07 | 481 | 88 | 13 | int:NANOG |
| Interaction | SSBP4 interactions | 2.18e-07 | 59 | 88 | 6 | int:SSBP4 | |
| Interaction | SOX9 interactions | 2.22e-07 | 97 | 88 | 7 | int:SOX9 | |
| Interaction | TFCP2L1 interactions | 2.55e-07 | 99 | 88 | 7 | int:TFCP2L1 | |
| Interaction | SMC5 interactions | TRIM33 SRRT NCOA6 SALL1 CHERP SNAP91 ATXN2 WDR33 PHF3 POLDIP3 PRRC2C SMARCA4 SMARCC1 SRRM2 ZNF281 SS18 TIPARP SCAF4 | 2.56e-07 | 1000 | 88 | 18 | int:SMC5 |
| Interaction | FEV interactions | 2.57e-07 | 203 | 88 | 9 | int:FEV | |
| Interaction | ARID1A interactions | ATG7 SMARCA4 SMARCC1 SMARCD3 SALL4 SS18 CREBBP EP300 TIPARP HDAC1 | 3.48e-07 | 276 | 88 | 10 | int:ARID1A |
| Interaction | BAG2 interactions | KIAA1671 NCOA2 FOXO1 TRIM33 NCOA6 PRRC2C ARHGAP17 PRKCI SRRM2 SP110 CREBBP EP300 TIPARP HDAC1 | 4.82e-07 | 622 | 88 | 14 | int:BAG2 |
| Interaction | GCM1 interactions | 5.14e-07 | 68 | 88 | 6 | int:GCM1 | |
| Interaction | CHD4 interactions | ZNF462 SRRT SALL1 CHERP ZFHX4 POLDIP3 PRRC2C SMARCA4 SMARCC1 SALL4 PRKCI SSBP4 SRRM2 VARS1 EP300 TIPARP HDAC1 | 5.30e-07 | 938 | 88 | 17 | int:CHD4 |
| Interaction | KLF1 interactions | 5.53e-07 | 37 | 88 | 5 | int:KLF1 | |
| Interaction | ETV4 interactions | 5.61e-07 | 69 | 88 | 6 | int:ETV4 | |
| Interaction | TLX3 interactions | NCOA2 MSX2 BCL9L NCOA6 SALL1 ZFHX4 POLDIP3 BCL9 ZNF281 EP300 | 5.65e-07 | 291 | 88 | 10 | int:TLX3 |
| Interaction | CNOT9 interactions | KIAA1671 SALL1 ATXN2 PRRC2C MINK1 ANKRD17 PRKCI MAP4K4 RBM20 | 7.61e-07 | 231 | 88 | 9 | int:CNOT9 |
| Interaction | FUS interactions | FOXO1 SRRT FNDC3B NCOA6 CHERP TOX WDR33 PHF3 SMARCA4 SMARCC1 SS18 CREBBP EP300 TIPARP SCAF4 | 9.00e-07 | 757 | 88 | 15 | int:FUS |
| Interaction | DDIT3 interactions | 9.48e-07 | 120 | 88 | 7 | int:DDIT3 | |
| Interaction | ETS1 interactions | 1.00e-06 | 121 | 88 | 7 | int:ETS1 | |
| Interaction | YWHAG interactions | KIAA1671 FOXO1 CASC3 SYNRG NCOA6 KANK1 PHF3 MAP4K5 PRRC2C MINK1 ANKRD17 ARHGAP17 PRKCI SRRM2 SS18 MAP4K4 DENND1A ENKD1 SEC23B | 1.44e-06 | 1248 | 88 | 19 | int:YWHAG |
| Interaction | STAT2 interactions | 1.46e-06 | 81 | 88 | 6 | int:STAT2 | |
| Interaction | SALL4 interactions | 1.68e-06 | 83 | 88 | 6 | int:SALL4 | |
| Interaction | EWSR1 interactions | TRIM33 BCL9L SRRT CASC3 NCOA6 CHERP CECR2 SMARCA4 SMARCC1 ARHGAP17 SALL4 REST BCL9 ZNF281 CREBBP EP300 | 1.69e-06 | 906 | 88 | 16 | int:EWSR1 |
| Interaction | SMARCA5 interactions | SRRT ATG7 CECR2 SMARCA4 SMARCC1 REST SS18 MAP4K4 VARS1 TIPARP HDAC1 | 1.91e-06 | 415 | 88 | 11 | int:SMARCA5 |
| Interaction | ESRRB interactions | 2.16e-06 | 262 | 88 | 9 | int:ESRRB | |
| Interaction | WWTR1 interactions | KIAA1671 NCOA2 SYNRG NCOA6 PHF3 PRRC2C SMARCA4 SMARCC1 MAP4K4 CREBBP EP300 | 2.24e-06 | 422 | 88 | 11 | int:WWTR1 |
| Interaction | SS18 interactions | 2.37e-06 | 88 | 88 | 6 | int:SS18 | |
| Interaction | SOX2 interactions | KIAA1671 NCOA2 ZNF462 TRIM33 BCL9L NCOA6 SALL1 ZFHX4 POLDIP3 SMARCA4 SMARCC1 ANKRD17 SALL4 BCL9 ZNF281 SS18 EP300 MEIS2 TIPARP HDAC1 | 2.44e-06 | 1422 | 88 | 20 | int:SOX2 |
| Interaction | FOXI1 interactions | 3.08e-06 | 92 | 88 | 6 | int:FOXI1 | |
| Interaction | SMARCC2 interactions | TRIM33 SMARCA4 SMARCC1 SMARCD3 REST SS18 CREBBP EP300 TIPARP HDAC1 | 3.22e-06 | 353 | 88 | 10 | int:SMARCC2 |
| Interaction | SNRNP40 interactions | ZNF462 BCL9L SRRT CHERP POLDIP3 SMARCA4 SMARCC1 BCL9 SRRM2 ZNF281 VARS1 RBM20 SCAF4 | 3.79e-06 | 637 | 88 | 13 | int:SNRNP40 |
| Interaction | CIITA interactions | 4.15e-06 | 55 | 88 | 5 | int:CIITA | |
| Interaction | CBX3 interactions | ZNF462 TRIM33 SRRT ATG7 PHF3 SMARCA4 REST SRRM2 SP110 ZNF281 MAP4K4 EP300 TIPARP | 4.41e-06 | 646 | 88 | 13 | int:CBX3 |
| Interaction | SS18L1 interactions | 4.45e-06 | 98 | 88 | 6 | int:SS18L1 | |
| Interaction | SMARCE1 interactions | 4.54e-06 | 287 | 88 | 9 | int:SMARCE1 | |
| Interaction | HDAC1 interactions | KIAA1671 MSX2 SRRT SALL1 ZFHX4 SMARCA4 SMARCC1 ANKRD17 SALL4 REST SS18 CREBBP VARS1 RBM20 EP300 TIPARP HDAC1 | 5.12e-06 | 1108 | 88 | 17 | int:HDAC1 |
| Interaction | LHX6 interactions | 5.40e-06 | 58 | 88 | 5 | int:LHX6 | |
| Interaction | BMI1 interactions | SRRT CASC3 CHERP ATXN2 WDR33 PHF3 PRRC2C PNMA2 SMARCA4 SMARCC1 CREBBP EP300 SEC23B | 5.47e-06 | 659 | 88 | 13 | int:BMI1 |
| Interaction | SOX6 interactions | 5.70e-06 | 157 | 88 | 7 | int:SOX6 | |
| Interaction | CEBPA interactions | NCOA2 MSX2 TRIM33 NCOA6 ATXN2 POLDIP3 PRRC2C SMARCA4 SMARCC1 BCL9 SRRM2 SP110 ZNF281 CREBBP VARS1 EP300 HDAC1 SCAF4 | 5.89e-06 | 1245 | 88 | 18 | int:CEBPA |
| Interaction | NACC1 interactions | 5.94e-06 | 103 | 88 | 6 | int:NACC1 | |
| Interaction | NCOA3 interactions | 6.16e-06 | 224 | 88 | 8 | int:NCOA3 | |
| Interaction | SSBP2 interactions | 6.64e-06 | 105 | 88 | 6 | int:SSBP2 | |
| Interaction | POU5F1 interactions | ZNF462 TRIM33 SALL1 WDR33 PHF3 SMARCA4 SMARCC1 ANKRD17 SALL4 ZNF281 HDAC1 ZIC3 | 8.65e-06 | 584 | 88 | 12 | int:POU5F1 |
| Interaction | RXRA interactions | 9.24e-06 | 169 | 88 | 7 | int:RXRA | |
| Interaction | GATA1 interactions | 9.98e-06 | 171 | 88 | 7 | int:GATA1 | |
| Interaction | CPSF2 interactions | 1.08e-05 | 173 | 88 | 7 | int:CPSF2 | |
| Interaction | BICRA interactions | 1.10e-05 | 67 | 88 | 5 | int:BICRA | |
| Interaction | NR1H4 interactions | 1.11e-05 | 32 | 88 | 4 | int:NR1H4 | |
| Interaction | LDB1 interactions | 1.12e-05 | 115 | 88 | 6 | int:LDB1 | |
| Interaction | TAF15 interactions | FOXO1 CACNA1A TRIM33 SRRT CHERP SMARCA4 SMARCC1 REST EP300 TIPARP | 1.15e-05 | 408 | 88 | 10 | int:TAF15 |
| Interaction | TEAD1 interactions | 1.20e-05 | 176 | 88 | 7 | int:TEAD1 | |
| Interaction | ARID1B interactions | 1.25e-05 | 177 | 88 | 7 | int:ARID1B | |
| Interaction | RBBP7 interactions | ZNF462 SALL1 SMARCA4 SMARCC1 SALL4 REST CREBBP VARS1 EP300 TIPARP HDAC1 | 1.28e-05 | 507 | 88 | 11 | int:RBBP7 |
| Interaction | MDC1 interactions | TRIM33 ATXN2 WDR33 PHF3 SMARCA4 SMARCC1 SMARCD3 CREBBP EP300 TIPARP | 1.30e-05 | 414 | 88 | 10 | int:MDC1 |
| Interaction | SSBP3 interactions | 1.36e-05 | 119 | 88 | 6 | int:SSBP3 | |
| Interaction | FOSL1 interactions | 1.37e-05 | 70 | 88 | 5 | int:FOSL1 | |
| Interaction | ALG13 interactions | 1.55e-05 | 183 | 88 | 7 | int:ALG13 | |
| Interaction | LHX2 interactions | 1.55e-05 | 183 | 88 | 7 | int:LHX2 | |
| Interaction | SRCAP interactions | 1.98e-05 | 127 | 88 | 6 | int:SRCAP | |
| Interaction | SMARCA2 interactions | 2.03e-05 | 346 | 88 | 9 | int:SMARCA2 | |
| Interaction | TBL1XR1 interactions | 2.11e-05 | 192 | 88 | 7 | int:TBL1XR1 | |
| Interaction | PAX9 interactions | 2.26e-05 | 130 | 88 | 6 | int:PAX9 | |
| Interaction | CHD3 interactions | SRRT SALL1 CHERP ZFHX4 POLDIP3 PRRC2C SMARCA4 SMARCC1 SALL4 CREBBP EP300 TIPARP HDAC1 | 2.39e-05 | 757 | 88 | 13 | int:CHD3 |
| Interaction | RORA interactions | 2.48e-05 | 39 | 88 | 4 | int:RORA | |
| Interaction | CTTN interactions | KIAA1671 FOXO1 SRRT MAGEL2 ATG7 MAP4K5 SMARCA4 ARHGAP17 EP300 TIPARP | 2.66e-05 | 450 | 88 | 10 | int:CTTN |
| Interaction | NONO interactions | FOXO1 MAGEL2 SALL1 SMARCA4 SMARCC1 REST SRRM2 CREBBP EP300 TIPARP HDAC1 | 2.67e-05 | 549 | 88 | 11 | int:NONO |
| Interaction | CTNNB1 interactions | KIAA1671 TGFB3 NCOA2 FOXO1 TRIM33 BCL9L SALL1 POLDIP3 SMARCA4 BCL9 SRRM2 CREBBP EP300 HDAC1 ZIC3 | 2.88e-05 | 1009 | 88 | 15 | int:CTNNB1 |
| Interaction | PPARGC1A interactions | 2.96e-05 | 82 | 88 | 5 | int:PPARGC1A | |
| Interaction | DHX9 interactions | FOXO1 MSX2 TRIM33 SRRT MAGEL2 CHERP ATXN2 POLDIP3 REST SRRM2 EP300 STAT6 | 2.99e-05 | 662 | 88 | 12 | int:DHX9 |
| Interaction | ISL2 interactions | 3.04e-05 | 41 | 88 | 4 | int:ISL2 | |
| Interaction | BAZ1B interactions | 3.12e-05 | 204 | 88 | 7 | int:BAZ1B | |
| Cytoband | 2q37 | 2.94e-05 | 31 | 88 | 3 | 2q37 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.96e-05 | 17 | 57 | 3 | 486 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinase kinases | 9.71e-05 | 5 | 57 | 2 | 655 | |
| GeneFamily | UDP glucuronosyltransferases | 1.38e-04 | 32 | 57 | 3 | 363 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.45e-03 | 18 | 57 | 2 | 91 | |
| GeneFamily | G-patch domain containing|Minor histocompatibility antigens | 2.17e-03 | 22 | 57 | 2 | 579 | |
| GeneFamily | PHD finger proteins | 2.87e-03 | 90 | 57 | 3 | 88 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | TRIM33 ATXN2 PHF3 MAP4K5 PRRC2C ANKRD17 PRKCI CREBBP MEIS2 TIPARP | 3.04e-06 | 466 | 86 | 10 | M13522 |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_IFN_SUBSET_UP | 4.11e-06 | 33 | 86 | 4 | M41050 | |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | 1.12e-05 | 323 | 86 | 8 | M9150 | |
| Coexpression | ZHENG_FOXP3_TARGETS_IN_THYMUS_DN | 1.21e-05 | 14 | 86 | 3 | MM731 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NCOA2 TRIM33 ATXN2 PHF3 MAP4K5 PRRC2C ANKRD17 PRKCI MN1 CREBBP MEIS2 TIPARP | 2.27e-05 | 856 | 86 | 12 | M4500 |
| Coexpression | DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN | 2.79e-05 | 179 | 86 | 6 | M8519 | |
| Coexpression | GSE37416_CTRL_VS_0H_F_TULARENSIS_LVS_NEUTROPHIL_UP | 3.78e-05 | 189 | 86 | 6 | M5326 | |
| Coexpression | GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_48H_CD4_TCELL_UP | 3.78e-05 | 189 | 86 | 6 | M4199 | |
| Coexpression | GSE17974_0H_VS_48H_IN_VITRO_ACT_CD4_TCELL_UP | 4.13e-05 | 192 | 86 | 6 | M4174 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_IL12_72H_CD8_T_CELL_UP | 5.04e-05 | 199 | 86 | 6 | M3639 | |
| Coexpression | GSE31082_DN_VS_CD4_SP_THYMOCYTE_DN | 5.18e-05 | 200 | 86 | 6 | M5059 | |
| Coexpression | GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY3_DN | 5.18e-05 | 200 | 86 | 6 | M4632 | |
| Coexpression | SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5 | 7.94e-05 | 69 | 86 | 4 | M12001 | |
| Coexpression | GUO_HEX_TARGETS_UP | 1.28e-04 | 78 | 86 | 4 | M1436 | |
| Coexpression | GUO_HEX_TARGETS_UP | 1.41e-04 | 80 | 86 | 4 | MM626 | |
| Coexpression | BENPORATH_SOX2_TARGETS | FOXO1 CACNA1A KANK1 SALL1 POLDIP3 REST BCL9 ZNF281 SCAF4 ZIC3 | 1.45e-04 | 734 | 86 | 10 | M3835 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 1.51e-04 | 467 | 86 | 8 | M1347 | |
| Coexpression | LIU_CMYB_TARGETS_DN | 1.58e-04 | 6 | 86 | 2 | M9230 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | TRIM33 NCOA6 MAP4K5 NR4A2 SMARCC1 ANKRD17 ARHGAP17 TMCO6 PRKCI REST SP110 SEC23B STAT6 | 1.60e-04 | 1215 | 86 | 13 | M41122 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 1.92e-04 | 484 | 86 | 8 | MM999 | |
| Coexpression | BROWNE_HCMV_INFECTION_6HR_DN | 2.09e-04 | 164 | 86 | 5 | M10311 | |
| Coexpression | TIEN_INTESTINE_PROBIOTICS_6HR_DN | 2.47e-04 | 170 | 86 | 5 | M19990 | |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | NCOA2 TRIM33 PRRC2C MINK1 NR4A2 SMARCA4 SP110 MEIS2 HDAC1 STAT6 | 2.62e-04 | 790 | 86 | 10 | M12490 |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_RAG2_KO_NK_CELL_UP | 2.75e-04 | 174 | 86 | 5 | M8885 | |
| Coexpression | GSE32255_WT_UNSTIM_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_UP | 2.82e-04 | 175 | 86 | 5 | M8908 | |
| Coexpression | YAGUE_PRETUMOR_DRUG_RESISTANCE_UP | 2.94e-04 | 8 | 86 | 2 | M12825 | |
| Coexpression | BENPORATH_NOS_TARGETS | 3.13e-04 | 179 | 86 | 5 | M14573 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 3.21e-04 | 180 | 86 | 5 | M8239 | |
| Coexpression | MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP | 3.32e-04 | 41 | 86 | 3 | M1422 | |
| Coexpression | PUJANA_BREAST_CANCER_LIT_INT_NETWORK | 3.46e-04 | 101 | 86 | 4 | M15356 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP | 3.55e-04 | 184 | 86 | 5 | M8544 | |
| Coexpression | BENPORATH_OCT4_TARGETS | 3.90e-04 | 290 | 86 | 6 | M17183 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP | 3.92e-04 | 188 | 86 | 5 | MM983 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN | 4.41e-04 | 416 | 86 | 7 | MM1002 | |
| Coexpression | GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_12H_CD4_TCELL_UP | 4.52e-04 | 194 | 86 | 5 | M4192 | |
| Coexpression | GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_UP | 4.63e-04 | 195 | 86 | 5 | M4195 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 4.67e-04 | 300 | 86 | 6 | M8702 | |
| Coexpression | KRASNOSELSKAYA_ILF3_TARGETS_DN | 4.67e-04 | 46 | 86 | 3 | M12166 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_DC_UP | 5.08e-04 | 199 | 86 | 5 | M5399 | |
| Coexpression | GSE10239_NAIVE_VS_KLRG1HIGH_EFF_CD8_TCELL_UP | 5.08e-04 | 199 | 86 | 5 | M3052 | |
| Coexpression | GSE7831_1H_VS_4H_INFLUENZA_STIM_PDC_DN | 5.08e-04 | 199 | 86 | 5 | M6964 | |
| Coexpression | GSE8621_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN | 5.08e-04 | 199 | 86 | 5 | M6987 | |
| Coexpression | GSE3337_CTRL_VS_4H_IFNG_IN_CD8POS_DC_UP | 5.19e-04 | 200 | 86 | 5 | M5097 | |
| Coexpression | GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA2_STIM_CD8_TCELL_DN | 5.19e-04 | 200 | 86 | 5 | M8040 | |
| Coexpression | GSE15324_NAIVE_VS_ACTIVATED_CD8_TCELL_UP | 5.19e-04 | 200 | 86 | 5 | M3523 | |
| Coexpression | GSE14769_UNSTIM_VS_360MIN_LPS_BMDM_DN | 5.19e-04 | 200 | 86 | 5 | M3510 | |
| Coexpression | GSE21063_WT_VS_NFATC1_KO_8H_ANTI_IGM_STIM_BCELL_DN | 5.19e-04 | 200 | 86 | 5 | M8278 | |
| Coexpression | GSE17721_POLYIC_VS_CPG_0.5H_BMDC_DN | 5.19e-04 | 200 | 86 | 5 | M3933 | |
| Coexpression | GSE40068_CXCR5POS_BCL6POS_TFH_VS_CXCR5NEG_BCL6NEG_CD4_TCELL_UP | 5.19e-04 | 200 | 86 | 5 | M9258 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_0.5H_BMDC_DN | 5.19e-04 | 200 | 86 | 5 | M3877 | |
| Coexpression | GSE7460_CTRL_VS_TGFB_TREATED_ACT_CD8_TCELL_DN | 5.19e-04 | 200 | 86 | 5 | M5679 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | ZNF462 TMEM184A ATXN2 PRRC2C SMARCA4 SMARCC1 SALL4 REST MEIS2 TIPARP ZIC3 | 8.68e-07 | 403 | 88 | 11 | gudmap_developingGonad_e12.5_epididymis_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | ZNF462 MAGEL2 KIAA1549L TOX ZFHX4 ATG7 WDR33 SOBP CECR2 SLC26A5 SMARCD3 SALL4 BCL9 SP110 CREBBP MEIS2 | 2.32e-06 | 978 | 88 | 16 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | ZNF462 TMEM184A ATXN2 WDR33 PRRC2C SMARCA4 SMARCC1 ANKRD17 SALL4 REST CREBBP MEIS2 TIPARP ZIC3 | 5.46e-06 | 806 | 88 | 14 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#2_top-relative-expression-ranked_500 | 1.23e-05 | 72 | 88 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#2 | 1.31e-05 | 73 | 88 | 5 | Facebase_RNAseq_e9.5_Mandibular Arch_500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#2 | 2.48e-05 | 41 | 88 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | ZNF462 MAGEL2 ATG7 WDR33 SOBP CECR2 SLC26A5 SALL4 BCL9 CREBBP | 3.65e-05 | 492 | 88 | 10 | Facebase_RNAseq_e10.5_Mandibular Arch_500 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | 5.09e-05 | 232 | 88 | 7 | Facebase_RNAseq_e9.5_Maxillary Arch_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | NCOA2 CACNA1A NCOA6 MAGEL2 SALL1 KIAA1549L TOX SOBP CECR2 NR4A2 SMARCA4 SALL4 SCAF4 ZIC3 | 5.31e-05 | 989 | 88 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#5 | 6.31e-05 | 101 | 88 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 7.35e-05 | 169 | 88 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | 7.43e-05 | 334 | 88 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | ZFHX4 ATXN2 PRRC2C SMARCA4 SMARCC1 ANKRD17 SALL4 REST CREBBP MEIS2 TIPARP ZIC3 | 1.17e-04 | 804 | 88 | 12 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.32e-04 | 118 | 88 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.66e-04 | 196 | 88 | 6 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k3_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000 | TGFB3 CACNA1A KIAA1549L TOX TMEM184A ZFHX4 CECR2 SMARCD3 SALL4 SSBP4 SP110 MEIS2 ZIC3 | 1.69e-04 | 967 | 88 | 13 | Facebase_RNAseq_e9.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000 | TGFB3 CACNA1A SALL1 KIAA1549L TOX TMEM184A ZFHX4 CECR2 SLC26A5 SMARCD3 SALL4 SP110 MEIS2 | 1.70e-04 | 968 | 88 | 13 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | NCOA2 CACNA1A MAGEL2 SALL1 KIAA1549L TOX TMEM184A CECR2 SLC26A5 SALL4 BCL9 MEIS2 ZIC3 | 1.98e-04 | 983 | 88 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_500 | 2.15e-04 | 390 | 88 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#4_top-relative-expression-ranked_500 | 2.67e-04 | 75 | 88 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#5_top-relative-expression-ranked_500 | 2.87e-04 | 217 | 88 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500_k5 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_100 | 3.26e-04 | 79 | 88 | 4 | gudmap_developingGonad_e11.5_ovary + mesonephros_100 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_500 | 3.38e-04 | 417 | 88 | 8 | gudmap_developingGonad_e11.5_ovary + mesonephros_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.82e-04 | 229 | 88 | 6 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000_k1 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_200 | 4.83e-04 | 37 | 88 | 3 | gudmap_kidney_P0_CapMes_Crym_k3_200 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | ZNF462 ZFHX4 PRRC2C SMARCA4 SMARCC1 SALL4 REST CREBBP MEIS2 TIPARP ZIC3 | 5.39e-04 | 815 | 88 | 11 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | ZNF462 CACNA1A SYNRG MAGEL2 KIAA1549L TOX WDR33 CECR2 SMARCD3 MEIS2 | 5.54e-04 | 688 | 88 | 10 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K5 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_200 | 5.56e-04 | 161 | 88 | 5 | gudmap_developingGonad_e11.5_ovary + mesonephros_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#3 | 5.64e-04 | 39 | 88 | 3 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#4 | 5.64e-04 | 39 | 88 | 3 | Facebase_RNAseq_e10.5_Maxillary Arch_500_K4 | |
| CoexpressionAtlas | EB blastocyst_vs_EB bone marrow-Confounder_removed-fold2.0_adjp0.05 | 5.79e-04 | 345 | 88 | 7 | PCBC_ratio_EB blastocyst_vs_EB bone marrow_cfr-2X-p05 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#4 | 5.82e-04 | 248 | 88 | 6 | Facebase_RNAseq_e8.5_Floor Plate_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#2 | 5.95e-04 | 249 | 88 | 6 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_top-relative-expression-ranked_1000 | ZNF462 MAGEL2 SALL1 TOX ZFHX4 SNAP91 MAP4K5 PNMA2 NR4A2 SALL4 RBM20 | 6.08e-04 | 827 | 88 | 11 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | ZNF462 CACNA1A TRIM33 NCOA6 TOX LMX1B SLC26A5 NR4A2 SMARCC1 BCL9 SP110 ZNF281 SEC23B TIPARP | 6.09e-04 | 1252 | 88 | 14 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | KANK1 SALL1 KIAA1549L TOX TMEM184A ZFHX4 SOBP CECR2 SLC26A5 SMARCA4 SP110 MEIS2 | 7.32e-04 | 984 | 88 | 12 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_100 | 7.39e-04 | 98 | 88 | 4 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#1 | 7.39e-04 | 98 | 88 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.39e-04 | 98 | 88 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_100 | 7.39e-04 | 98 | 88 | 4 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_100 | |
| CoexpressionAtlas | ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_100 | 7.98e-04 | 100 | 88 | 4 | PCBC_ratio_ECTO_vs_SC_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_100 | 7.98e-04 | 100 | 88 | 4 | Facebase_RNAseq_e10.5_Mandibular Arch_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000 | ZNF462 MAGEL2 SALL1 KIAA1549L PHF3 PRRC2C CECR2 SLC26A5 SALL4 MAP4K4 HDAC1 ZIC3 | 8.00e-04 | 994 | 88 | 12 | Facebase_RNAseq_e8.5_Floor Plate_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#3_top-relative-expression-ranked_500 | 8.91e-04 | 103 | 88 | 4 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_500_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_500 | 8.97e-04 | 484 | 88 | 8 | Facebase_RNAseq_e9.5_Mandibular Arch_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | ZNF462 NCOA6 SALL1 KIAA1549L TOX LMX1B PHF3 CECR2 SLC26A5 SMARCC1 SALL4 HSD17B2 BCL9 ZNF281 TIPARP | 9.10e-04 | 1459 | 88 | 15 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#2_top-relative-expression-ranked_500 | 9.18e-04 | 46 | 88 | 3 | gudmap_developingGonad_e12.5_epididymis_k2_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 9.24e-04 | 271 | 88 | 6 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500 | 9.59e-04 | 489 | 88 | 8 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500_k-means-cluster#1 | 9.78e-04 | 47 | 88 | 3 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | 1.01e-03 | 493 | 88 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_top-relative-expression-ranked_500 | 1.02e-03 | 276 | 88 | 6 | gudmap_kidney_P1_CapMes_Crym_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500 | 1.04e-03 | 495 | 88 | 8 | Facebase_RNAseq_e10.5_Olfactory Pit_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_500 | 1.04e-03 | 495 | 88 | 8 | Facebase_RNAseq_e8.5_Floor Plate_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Ectoderm_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500 | 1.06e-03 | 497 | 88 | 8 | PCBC_ECTO_fibroblast_500 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_OlfPlac_2500_K3 | ZNF462 KANK1 SALL1 CHERP KIAA1549L LMX1B POLDIP3 CECR2 TMCO6 SALL4 PRKCI VARS1 TIPARP | 1.17e-03 | 1187 | 88 | 13 | facebase_RNAseq_e9.5_OlfPlac_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.20e-03 | 285 | 88 | 6 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K3 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_top-relative-expression-ranked_1000 | 1.32e-03 | 639 | 88 | 9 | gudmap_kidney_P0_CapMes_Crym_1000 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_200 | 1.39e-03 | 53 | 88 | 3 | gudmap_kidney_P1_CapMes_Crym_k4_200 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_top-relative-expression-ranked_500 | 1.40e-03 | 294 | 88 | 6 | gudmap_kidney_P0_CapMes_Crym_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 1.46e-03 | 54 | 88 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.47e-03 | 200 | 88 | 5 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K2 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.33e-06 | 193 | 88 | 6 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-06 | 194 | 88 | 6 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 2.70e-06 | 198 | 88 | 6 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-05 | 176 | 88 | 5 | 29cda51a99100ddd2928cadc92da40f001d7e1f4 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-05 | 176 | 88 | 5 | 01774a86d7d92f31a056b753f9844f923038003e | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.75e-05 | 178 | 88 | 5 | d3a75a8082e70543b84c35d53fe77625300d19fa | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.75e-05 | 178 | 88 | 5 | b2cda1df801b1a1a41e3dd2808baef37765cd804 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Mesenchymal_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.98e-05 | 181 | 88 | 5 | 9b2d207dc9fc2228a1555ed360286bb7c2d988ff | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.98e-05 | 181 | 88 | 5 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.06e-05 | 182 | 88 | 5 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.48e-05 | 187 | 88 | 5 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 3.95e-05 | 192 | 88 | 5 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 4.05e-05 | 193 | 88 | 5 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.05e-05 | 193 | 88 | 5 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | droplet-Tongue-TONGUE|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.36e-05 | 196 | 88 | 5 | 44a30b1a5f3d8c845e5f3bd17d8102a7449f555b | |
| ToppCell | droplet-Tongue-TONGUE-1m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.36e-05 | 196 | 88 | 5 | 9935bdb10789e8cfc922dca526ca3bf8317fe270 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M|organoid_Kanton_Nature / Sample Type, Dataset, Time_group, and Cell type. | 4.36e-05 | 196 | 88 | 5 | 1e9ccbd5be7839a74108f0cd07a6d2d736bc7f1b | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.36e-05 | 196 | 88 | 5 | a85f5f1e6acc798e9e02b1a21e0ffe87a323c333 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_DC1|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.46e-05 | 197 | 88 | 5 | 9a3d0b7f4788487d024d56bc776a2fd1149f50d5 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 4.68e-05 | 199 | 88 | 5 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | droplet-Trachea|droplet / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.68e-05 | 199 | 88 | 5 | 1c7d30765ddb2291967da5d15664c6238c680c1d | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 4.68e-05 | 199 | 88 | 5 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | droplet-Trachea|droplet / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.68e-05 | 199 | 88 | 5 | b9038a1ccf3ef3123e2e39afbe6213c363437443 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.68e-05 | 199 | 88 | 5 | 4217b9e66c5374461e84bdb893ab650f148286c8 | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 4.79e-05 | 200 | 88 | 5 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | Myeloid-Myeloid-C_(Cd16+_Monocyte)|Myeloid / shred on cell class and cell subclass (v4) | 8.56e-05 | 117 | 88 | 4 | d1936e76a935216783a73ab414e4147fa48e68eb | |
| Drug | afloqualone | 2.51e-07 | 15 | 86 | 4 | CID000002040 | |
| Drug | AC1ND2OB | 7.20e-07 | 265 | 86 | 9 | CID004568637 | |
| Drug | TCPOBOP | 1.62e-06 | 95 | 86 | 6 | CID000005382 | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 3.89e-06 | 171 | 86 | 7 | 7535_DN | |
| Drug | AC1MRQNQ | 4.30e-06 | 9 | 86 | 3 | CID003522271 | |
| Drug | DHPASiU | 4.30e-06 | 9 | 86 | 3 | CID000197602 | |
| Drug | 3-iodophenol | 4.30e-06 | 9 | 86 | 3 | CID000012272 | |
| Drug | AC1L4J7U | 4.30e-06 | 9 | 86 | 3 | CID000186631 | |
| Drug | Chebi:32663 | 4.30e-06 | 9 | 86 | 3 | CID005460873 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 6.30e-06 | 184 | 86 | 7 | 2321_DN | |
| Drug | Nifuroxazide [965-52-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 7.25e-06 | 188 | 86 | 7 | 4835_DN | |
| Drug | 4-nitrophenyl)imidazole | 8.40e-06 | 11 | 86 | 3 | CID000123155 | |
| Drug | AC1O5XMV | 8.40e-06 | 11 | 86 | 3 | CID006442661 | |
| Drug | N-OH-DABZ | 1.12e-05 | 12 | 86 | 3 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 1.12e-05 | 12 | 86 | 3 | CID000088735 | |
| Drug | 2,4,6-TCB | 1.12e-05 | 12 | 86 | 3 | CID000037247 | |
| Drug | nonanoyl-N-methylglucamide | 1.12e-05 | 12 | 86 | 3 | CID000160090 | |
| Drug | 7,7,7-triphenylheptanoic acid | 1.12e-05 | 12 | 86 | 3 | CID000276709 | |
| Drug | afloqualone | 1.41e-05 | 2 | 86 | 2 | ctd:C033541 | |
| Drug | tritanol | 1.45e-05 | 13 | 86 | 3 | CID000006457 | |
| Drug | 5-azido-UDP-glucuronic acid | 1.45e-05 | 13 | 86 | 3 | CID003081279 | |
| Drug | cotinine-N-glucuronide | 1.45e-05 | 13 | 86 | 3 | CID000000411 | |
| Drug | 5 alpha-androstane | 1.67e-05 | 84 | 86 | 5 | CID000094144 | |
| Drug | propranolol glucuronide | 1.84e-05 | 14 | 86 | 3 | CID000119515 | |
| Drug | PCB-61 | 1.84e-05 | 14 | 86 | 3 | CID000036401 | |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 2.29e-05 | 15 | 86 | 3 | CID000040469 | |
| Drug | naphthyl sulphate | 2.29e-05 | 15 | 86 | 3 | CID000114775 | |
| Drug | coumarin-3-carboxylic acid | 2.29e-05 | 15 | 86 | 3 | CID000010752 | |
| Drug | sulforaphane nitrile | 2.29e-05 | 15 | 86 | 3 | CID000543743 | |
| Drug | quercetin-3,4'-diglucoside | 2.81e-05 | 16 | 86 | 3 | CID005320835 | |
| Drug | 1'-hydroxyestragole | 2.81e-05 | 16 | 86 | 3 | CID000040003 | |
| Drug | bilirubin-phosphate | 2.81e-05 | 16 | 86 | 3 | CID005497144 | |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | 3.41e-05 | 17 | 86 | 3 | CID000003573 | |
| Drug | 6-hydroxychrysene | 3.41e-05 | 17 | 86 | 3 | CID000037766 | |
| Drug | EM-652 | 3.53e-05 | 49 | 86 | 4 | CID000155435 | |
| Drug | SureCN12722713 | 4.08e-05 | 18 | 86 | 3 | CID005488034 | |
| Drug | ethyl-beta-D-6-glucosiduronic acid | 4.08e-05 | 18 | 86 | 3 | CID000152226 | |
| Drug | Br 2 | 4.08e-05 | 18 | 86 | 3 | CID003060900 | |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | 4.08e-05 | 18 | 86 | 3 | CID000036614 | |
| Drug | ApApG | 4.08e-05 | 18 | 86 | 3 | CID003081975 | |
| Drug | C1 11-32 | 4.08e-05 | 18 | 86 | 3 | CID000443077 | |
| Drug | C11131 | 4.08e-05 | 18 | 86 | 3 | CID000443076 | |
| Drug | C2-MPAcid | 4.14e-05 | 51 | 86 | 4 | CID000508230 | |
| Drug | (+/-)-Abacavir | 4.14e-05 | 51 | 86 | 4 | CID000001971 | |
| Drug | Finrazole | 4.14e-05 | 51 | 86 | 4 | CID000178036 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 4.55e-05 | 170 | 86 | 6 | 1050_DN | |
| Drug | 9-OH-risperidone | 4.83e-05 | 19 | 86 | 3 | CID000475100 | |
| Drug | 5alpha-spirostan-3beta-ol | 4.83e-05 | 19 | 86 | 3 | CID000091433 | |
| Drug | almokalant | 4.83e-05 | 19 | 86 | 3 | CID003033962 | |
| Drug | tectochrysin | 5.66e-05 | 20 | 86 | 3 | CID005281954 | |
| Drug | AC1L1OBF | 5.66e-05 | 20 | 86 | 3 | CID000032736 | |
| Drug | 4'-hydroxydiclofenac | 5.66e-05 | 20 | 86 | 3 | CID000116545 | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 5.70e-05 | 177 | 86 | 6 | 1645_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 6.25e-05 | 180 | 86 | 6 | 4541_DN | |
| Drug | estriol-16-glucuronide | 6.59e-05 | 21 | 86 | 3 | CID000122281 | |
| Drug | dulcin | 6.59e-05 | 21 | 86 | 3 | CID000009013 | |
| Drug | Benzamidoxime hydrochloride | 6.59e-05 | 21 | 86 | 3 | CID000069186 | |
| Drug | cis isomer | 6.89e-05 | 58 | 86 | 4 | CID006474725 | |
| Drug | amonafide | 7.61e-05 | 22 | 86 | 3 | CID000050515 | |
| Drug | N-methylpiperazine | 7.61e-05 | 22 | 86 | 3 | CID000053167 | |
| Drug | amidoxime | 8.72e-05 | 23 | 86 | 3 | CID000465967 | |
| Drug | estradiol-3-glucuronide | 8.72e-05 | 23 | 86 | 3 | CID000066651 | |
| Drug | phenanthridine | 8.72e-05 | 23 | 86 | 3 | CID000009189 | |
| Drug | Bambuterol hydrochloride [81732-46-9]; Down 200; 10uM; MCF7; HT_HG-U133A | 9.73e-05 | 195 | 86 | 6 | 7239_DN | |
| Drug | STOCK1N-35874; Up 200; 14uM; PC3; HT_HG-U133A | 9.73e-05 | 195 | 86 | 6 | 6561_UP | |
| Drug | Cefepime hydrochloride [123171-59-5]; Down 200; 7.4uM; HL60; HT_HG-U133A | 9.73e-05 | 195 | 86 | 6 | 6159_DN | |
| Drug | AS-3201 | 9.94e-05 | 24 | 86 | 3 | CID000153948 | |
| Drug | Triamterene [396-01-0]; Down 200; 15.8uM; PC3; HT_HG-U133A | 1.00e-04 | 196 | 86 | 6 | 1819_DN | |
| Drug | Diflunisal [22494-42-4]; Up 200; 16uM; HL60; HG-U133A | 1.00e-04 | 196 | 86 | 6 | 1990_UP | |
| Drug | Famprofazone [22881-35-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 1.00e-04 | 196 | 86 | 6 | 6029_DN | |
| Drug | Iobenguane sulfate; Down 200; 10.8uM; HL60; HG-U133A | 1.00e-04 | 196 | 86 | 6 | 1729_DN | |
| Drug | Meclofenamic acid sodium salt monohydrate [6385-02-0]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.03e-04 | 197 | 86 | 6 | 2128_DN | |
| Drug | Ursolic acid [77-52-1]; Down 200; 8.8uM; PC3; HT_HG-U133A | 1.03e-04 | 197 | 86 | 6 | 2067_DN | |
| Drug | Todralazine hydrochloride [3778-76-5]; Down 200; 14.8uM; PC3; HT_HG-U133A | 1.03e-04 | 197 | 86 | 6 | 5087_DN | |
| Drug | Iopamidol [60166-93-0]; Down 200; 5.2uM; MCF7; HT_HG-U133A | 1.03e-04 | 197 | 86 | 6 | 3473_DN | |
| Drug | Morantel tartrate [26155-31-7]; Down 200; 10.8uM; PC3; HT_HG-U133A | 1.03e-04 | 197 | 86 | 6 | 1798_DN | |
| Drug | Atropine sulfate monohydrate [5908-99-6]; Down 200; 5.8uM; PC3; HT_HG-U133A | 1.03e-04 | 197 | 86 | 6 | 5865_DN | |
| Drug | (-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Down 200; 12.2uM; PC3; HT_HG-U133A | 1.03e-04 | 197 | 86 | 6 | 5108_DN | |
| Drug | (R) -Naproxen sodium salt [26159-34-2]; Down 200; 15.8uM; PC3; HT_HG-U133A | 1.03e-04 | 197 | 86 | 6 | 7146_DN | |
| Drug | benserazide hydrochloride; Up 200; 10uM; SKMEL5; HG-U133A | 1.06e-04 | 198 | 86 | 6 | 631_UP | |
| Drug | Chlorhexidine [55-56-1]; Down 200; 8uM; PC3; HT_HG-U133A | 1.06e-04 | 198 | 86 | 6 | 6302_DN | |
| Drug | Adrenosterone [382-45-6]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 1.06e-04 | 198 | 86 | 6 | 5464_UP | |
| Drug | STOCK1N-28457; Down 200; 20uM; PC3; HT_HG-U133A | 1.06e-04 | 198 | 86 | 6 | 6864_DN | |
| Drug | Dimenhydrinate [523-87-5]; Up 200; 8.6uM; PC3; HT_HG-U133A | 1.06e-04 | 198 | 86 | 6 | 6352_UP | |
| Drug | Merbromin [129-16-8]; Down 200; 5uM; PC3; HT_HG-U133A | 1.09e-04 | 199 | 86 | 6 | 7398_DN | |
| Drug | 1,1-dimethylbiguanide hydrochloride; Up 200; 10uM; MCF7; HG-U133A | 1.09e-04 | 199 | 86 | 6 | 61_UP | |
| Drug | 2-Chloropyrazine [14508-49-7]; Up 200; 35uM; MCF7; HT_HG-U133A | 1.12e-04 | 200 | 86 | 6 | 6227_UP | |
| Drug | 5-MOP | 1.13e-04 | 25 | 86 | 3 | CID000002355 | |
| Drug | AzMC | 1.13e-04 | 25 | 86 | 3 | CID000064986 | |
| Drug | N-acetylbenzidine | 1.13e-04 | 25 | 86 | 3 | CID000018787 | |
| Drug | 5,6-benzoquinoline | 1.13e-04 | 25 | 86 | 3 | CID000006796 | |
| Drug | N-phenylmaleimide | 1.13e-04 | 25 | 86 | 3 | CID000013662 | |
| Drug | ethoxytriethyleneglycol | 1.14e-04 | 66 | 86 | 4 | CID000008190 | |
| Drug | AC1L1FK5 | 1.30e-04 | 129 | 86 | 5 | CID000003272 | |
| Drug | 3,4-dimethoxy-N-((2,2-dimethyl-2H-chromen-6-yl)methyl)-N-phenylbenzenesulfonamide | 1.40e-04 | 5 | 86 | 2 | ctd:C575894 | |
| Drug | MF101 extract | 1.40e-04 | 5 | 86 | 2 | ctd:C517398 | |
| Drug | diflunisal | 1.43e-04 | 27 | 86 | 3 | CID000003059 | |
| Drug | DiMeIQx | 1.43e-04 | 27 | 86 | 3 | CID000104739 | |
| Drug | CARMINE | 1.59e-04 | 28 | 86 | 3 | CID000014749 | |
| Drug | erucin | 1.59e-04 | 28 | 86 | 3 | CID000078160 | |
| Disease | X-11793--oxidized bilirubin measurement | 1.19e-06 | 8 | 83 | 3 | EFO_0021260 | |
| Disease | Succinimide measurement | 1.19e-06 | 8 | 83 | 3 | EFO_0022118 | |
| Disease | X-11530 measurement | 1.19e-06 | 8 | 83 | 3 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 1.19e-06 | 8 | 83 | 3 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 1.19e-06 | 8 | 83 | 3 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 1.19e-06 | 8 | 83 | 3 | EFO_0800696 | |
| Disease | X-10458 measurement | 1.19e-06 | 8 | 83 | 3 | EFO_0800692 | |
| Disease | X-24849 measurement | 1.19e-06 | 8 | 83 | 3 | EFO_0800909 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 1.19e-06 | 8 | 83 | 3 | EFO_0802740 | |
| Disease | X-16946 measurement | 1.19e-06 | 8 | 83 | 3 | EFO_0800766 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.34e-06 | 195 | 83 | 7 | DOID:1574 (implicated_via_orthology) | |
| Disease | X-11442 measurement | 1.78e-06 | 9 | 83 | 3 | EFO_0021236 | |
| Disease | X-11441 measurement | 1.78e-06 | 9 | 83 | 3 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 1.78e-06 | 9 | 83 | 3 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 1.78e-06 | 9 | 83 | 3 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 1.78e-06 | 9 | 83 | 3 | EFO_0801036 | |
| Disease | X-11880 measurement | 1.78e-06 | 9 | 83 | 3 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 1.78e-06 | 9 | 83 | 3 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 1.78e-06 | 9 | 83 | 3 | EFO_0802127 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 1.78e-06 | 9 | 83 | 3 | EFO_0004570, GO_0009410 | |
| Disease | bilirubin measurement, response to tenofovir | 2.54e-06 | 10 | 83 | 3 | EFO_0004570, EFO_0009279 | |
| Disease | X-21448 measurement | 2.54e-06 | 10 | 83 | 3 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 2.54e-06 | 10 | 83 | 3 | EFO_0802185 | |
| Disease | X-23974 measurement | 2.54e-06 | 10 | 83 | 3 | EFO_0800867 | |
| Disease | histidine betaine (hercynine) measurement | 3.48e-06 | 11 | 83 | 3 | EFO_0800972 | |
| Disease | X-21796 measurement | 3.48e-06 | 11 | 83 | 3 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 3.48e-06 | 11 | 83 | 3 | EFO_0004570, EFO_0004698 | |
| Disease | aldosterone measurement | 3.48e-06 | 11 | 83 | 3 | EFO_0010219 | |
| Disease | p-cresol glucuronide measurement | 4.64e-06 | 12 | 83 | 3 | EFO_0800079 | |
| Disease | biliverdin measurement | 4.64e-06 | 12 | 83 | 3 | EFO_0021033 | |
| Disease | retinol dehydrogenase 16 measurement | 6.01e-06 | 13 | 83 | 3 | EFO_0802007 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 7.82e-06 | 2 | 83 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 7.82e-06 | 2 | 83 | 2 | cv:C4551859 | |
| Disease | Menke-Hennekam syndrome | 7.82e-06 | 2 | 83 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 7.82e-06 | 2 | 83 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 7.82e-06 | 2 | 83 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 7.82e-06 | 2 | 83 | 2 | C4551859 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 7.82e-06 | 2 | 83 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | Rubinstein-Taybi Syndrome | 7.82e-06 | 2 | 83 | 2 | C0035934 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 1.42e-05 | 17 | 83 | 3 | EFO_0004611, EFO_0007800 | |
| Disease | angiopoietin-related protein 1 measurement | 1.70e-05 | 18 | 83 | 3 | EFO_0801382 | |
| Disease | Diffuse Large B-Cell Lymphoma | 1.78e-05 | 55 | 83 | 4 | C0079744 | |
| Disease | urate measurement, spine bone mineral density | 2.20e-05 | 58 | 83 | 4 | EFO_0004531, EFO_0007701 | |
| Disease | corneal hysteresis | 2.36e-05 | 20 | 83 | 3 | EFO_0010066 | |
| Disease | Craniosynostosis | 2.36e-05 | 20 | 83 | 3 | C0010278 | |
| Disease | tissue factor measurement | 2.75e-05 | 21 | 83 | 3 | EFO_0010623 | |
| Disease | Renal glomerular disease | 3.65e-05 | 23 | 83 | 3 | C0268731 | |
| Disease | Glomerulopathy Assessment | 3.65e-05 | 23 | 83 | 3 | C4521256 | |
| Disease | Keratoconus | 4.67e-05 | 4 | 83 | 2 | C0022578 | |
| Disease | eye measurement | 5.98e-05 | 27 | 83 | 3 | EFO_0004731 | |
| Disease | xanthurenate measurement | 7.44e-05 | 29 | 83 | 3 | EFO_0010551 | |
| Disease | prostate cancer (is_marker_for) | 8.07e-05 | 156 | 83 | 5 | DOID:10283 (is_marker_for) | |
| Disease | response to dolutegravir | 8.25e-05 | 30 | 83 | 3 | EFO_0600017 | |
| Disease | cholelithiasis | 1.13e-04 | 88 | 83 | 4 | EFO_0004799 | |
| Disease | Mitral valve prolapse | 1.43e-04 | 36 | 83 | 3 | HP_0001634 | |
| Disease | hearing impairment | 1.72e-04 | 98 | 83 | 4 | C1384666 | |
| Disease | level of Triacylglycerol (53:4) in blood serum | 2.16e-04 | 8 | 83 | 2 | OBA_2045166 | |
| Disease | gallstones | 2.50e-04 | 108 | 83 | 4 | EFO_0004210 | |
| Disease | corneal topography | 2.59e-04 | 109 | 83 | 4 | EFO_0004345 | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 2.78e-04 | 9 | 83 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | level of Sterol ester (27:1/16:1) in blood serum | 2.78e-04 | 9 | 83 | 2 | OBA_2045190 | |
| Disease | Coffin-Siris syndrome (implicated_via_orthology) | 2.78e-04 | 9 | 83 | 2 | DOID:1925 (implicated_via_orthology) | |
| Disease | Parkinson disease, late-onset | 3.47e-04 | 10 | 83 | 2 | cv:C3160718 | |
| Disease | PARKINSON DISEASE, LATE-ONSET | 3.47e-04 | 10 | 83 | 2 | 168600 | |
| Disease | vitamin D measurement | 3.77e-04 | 336 | 83 | 6 | EFO_0004631 | |
| Disease | pregnenetriol sulfate measurement | 4.23e-04 | 11 | 83 | 2 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 4.23e-04 | 11 | 83 | 2 | EFO_0600039 | |
| Disease | puberty onset measurement | 4.35e-04 | 125 | 83 | 4 | EFO_0005677 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 4.62e-04 | 127 | 83 | 4 | EFO_0008595, EFO_0020947 | |
| Disease | neutrophil count | FOXO1 CACNA1A TRIM33 SALL1 ATXN2 WDR33 MAP4K5 REST SSBP4 BCL9 MAP4K4 CREBBP | 4.73e-04 | 1382 | 83 | 12 | EFO_0004833 |
| Disease | esterified cholesterol measurement | 4.76e-04 | 128 | 83 | 4 | EFO_0008589 | |
| Disease | Small cell carcinoma of lung | 4.80e-04 | 54 | 83 | 3 | C0149925 | |
| Disease | Secondary Open Angle Glaucoma | 5.07e-04 | 12 | 83 | 2 | C0271148 | |
| Disease | PARKINSON DISEASE, LATE-ONSET | 5.07e-04 | 12 | 83 | 2 | C3160718 | |
| Disease | alpha-hydroxybutyric acid measurement | 5.07e-04 | 12 | 83 | 2 | EFO_0010458 | |
| Disease | Glaucoma, Open-Angle | 5.07e-04 | 12 | 83 | 2 | C0017612 | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 5.63e-04 | 57 | 83 | 3 | EFO_0022284 | |
| Disease | ovarian neoplasm | 5.66e-04 | 134 | 83 | 4 | C0919267 | |
| Disease | pregnenetriol disulfate measurement | 5.98e-04 | 13 | 83 | 2 | EFO_0800587 | |
| Disease | Glaucoma, Primary Open Angle | 5.98e-04 | 13 | 83 | 2 | C0339573 | |
| Disease | level of Sphingomyelin (d34:2) in blood serum | 5.98e-04 | 13 | 83 | 2 | OBA_2045174 | |
| Disease | Malignant neoplasm of ovary | 6.15e-04 | 137 | 83 | 4 | C1140680 | |
| Disease | free cholesterol measurement, low density lipoprotein cholesterol measurement | 6.15e-04 | 137 | 83 | 4 | EFO_0004611, EFO_0008591 | |
| Disease | free androgen index | 6.62e-04 | 374 | 83 | 6 | EFO_0007005 | |
| Disease | response to 5-fluorouracil, response to cyclophosphamide, chemotherapy-induced alopecia, response to doxorubicin | 6.96e-04 | 14 | 83 | 2 | EFO_0005400, GO_0036275, GO_1902518, GO_1902520 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 6.96e-04 | 14 | 83 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | carcinoma (implicated_via_orthology) | 7.90e-04 | 64 | 83 | 3 | DOID:305 (implicated_via_orthology) | |
| Disease | Situs ambiguus | 8.02e-04 | 15 | 83 | 2 | C0266642 | |
| Disease | hepatoblastoma (is_marker_for) | 8.02e-04 | 15 | 83 | 2 | DOID:687 (is_marker_for) | |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 8.02e-04 | 15 | 83 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | keratoconus | 8.64e-04 | 66 | 83 | 3 | MONDO_0015486 | |
| Disease | testosterone measurement | UGT1A4 CASC3 NCOA6 ZFHX4 MAP4K5 CECR2 UGT1A5 HSD17B2 USH2A SS18 VARS1 | 8.74e-04 | 1275 | 83 | 11 | EFO_0004908 |
| Disease | non-high density lipoprotein cholesterol measurement | 8.96e-04 | 713 | 83 | 8 | EFO_0005689 | |
| Disease | eosinophil count | FOXO1 CDIP1 SALL1 CHERP ATXN2 MAP4K5 TNFSF8 SMARCA4 PRKCI REST MAP4K4 STAT6 | 9.07e-04 | 1488 | 83 | 12 | EFO_0004842 |
| Disease | level of Sterol ester (27:1/18:1) in blood serum | 9.14e-04 | 16 | 83 | 2 | OBA_2045195 | |
| Disease | Alcoholic Intoxication, Chronic | 9.71e-04 | 268 | 83 | 5 | C0001973 | |
| Disease | Craniofacial Abnormalities | 9.99e-04 | 156 | 83 | 4 | C0376634 | |
| Disease | colorectal cancer (is_marker_for) | 1.02e-03 | 157 | 83 | 4 | DOID:9256 (is_marker_for) | |
| Disease | X-21441 measurement | 1.03e-03 | 17 | 83 | 2 | EFO_0800814 | |
| Disease | Limb Deformities, Congenital | 1.03e-03 | 17 | 83 | 2 | C0206762 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PRPIMPNMVFIGGIN | 266 | P35503 | |
| MFQRMEPPSPTQEGG | 1986 | O00555 | |
| PRPAMMSVAQHGQPL | 2011 | Q09472 | |
| SPVQPNPMSPQQHML | 2271 | Q09472 | |
| MPQPGFIPPHMSADG | 61 | Q9H305 | |
| AMPPGHTRMPENQRL | 271 | Q9H0I2 | |
| LRMTLPSPHMPRPNQ | 66 | Q6PL45 | |
| VPLRDLPPMHMGQNP | 296 | Q8WW27 | |
| LPPMHMGQNPNKPRN | 301 | Q8WW27 | |
| QAPMGPRAASPMNHS | 736 | Q92793 | |
| QPMMRPPFGAAAVPG | 861 | O60641 | |
| NPGMGNPMIHRPMSD | 2476 | O75179 | |
| QMGAGAHPPMILPLP | 251 | Q96AQ1 | |
| QMGAAAHPPMILPLP | 251 | Q96LY2 | |
| GHVMDSRVMRPPVPP | 826 | Q9BXF3 | |
| LPNQPPSAMVMHPFT | 186 | Q5T481 | |
| YTMGSHGMRRPPPVN | 596 | Q7Z3E1 | |
| PPPMEHAQMEGAQIR | 631 | Q13127 | |
| MHPMRALFLIPRNPP | 236 | O95819 | |
| GRHSLPQEPVMPMDQ | 191 | P41743 | |
| VLMIHPPGARAPMTQ | 286 | Q9UJ55 | |
| SHPQRMPAFPGMDPA | 1716 | Q9BY89 | |
| RMLPHAPGVQMQAIP | 371 | Q13547 | |
| QMTPHPTQLRHGPPM | 411 | O14770 | |
| QGNARMMAPPTHAQP | 1071 | Q99700 | |
| PQPQAPLGMMTGLDH | 811 | Q14678 | |
| MHTGLPNPTNLEMPR | 751 | Q6ZVL6 | |
| LGQAMAHAPQPLLPM | 146 | Q9UL42 | |
| PMASGPGIIRMNNPA | 166 | Q14686 | |
| GPPSQLMGMHQQIVP | 616 | Q14686 | |
| PVQVPLPHPMQMSAL | 561 | Q12778 | |
| PGVNARGFNMSIPMP | 426 | O95352 | |
| RGFNMSIPMPGHPVN | 431 | O95352 | |
| IHMGAGPPPQFNRME | 496 | O15234 | |
| GMLVQPGMNLPHPGL | 571 | O15234 | |
| GQPPHMRRQGPPHIN | 621 | Q8IWX8 | |
| EVPMMSPNGSIPPIH | 66 | Q53EP0 | |
| DGINMPHSLPPRGMA | 536 | O00512 | |
| PRGMAPHPNMPGSQM | 546 | O00512 | |
| PHPNMPGSQMRLPGF | 551 | O00512 | |
| MIPGSQRHMEPGNNP | 661 | O00512 | |
| GHGSQEPPMVPQGRM | 1121 | O00512 | |
| MRPPAFLQQGMMGPH | 1316 | O00512 | |
| MGMNLPGQQPLSHEP | 1156 | Q86UU0 | |
| MPFPPRLQQPHGAMA | 1226 | Q86UU0 | |
| MVPHGLHQGVMSPPQ | 1411 | Q86UU0 | |
| HMLSPQGSLMGPPPQ | 1451 | Q86UU0 | |
| FGQMPMGTHTSPLQP | 896 | Q8TEH3 | |
| MLPPQDAHDLGMPPA | 211 | Q5JT82 | |
| MVPIPGPVGNKRMVH | 366 | Q9NW75 | |
| HFGQDKPMPRALRMP | 366 | P37059 | |
| MGIQQDPMHHQVPLP | 346 | O95104 | |
| RMHMGGQIPNTPVPD | 786 | Q9NSC2 | |
| RMHMGGQIPNTPLPE | 646 | Q9UJQ4 | |
| LSMMPQRAGNDPPGV | 81 | Q6ZNG9 | |
| LGELQPPMFDLHPMR | 211 | Q9Y4K4 | |
| PLMIPQANHMAGISP | 181 | E9PI22 | |
| AMAPLHPHPAGMRIN | 156 | Q9BY77 | |
| MHPMRALFLIPRNPP | 236 | Q8N4C8 | |
| QEPMRMPGEGHVPAL | 681 | Q10571 | |
| MQEPGRYSPPPRHMS | 116 | P35548 | |
| QMRFDGPLHVPMNPE | 191 | P43354 | |
| ANPRGVFMMCIPPPN | 331 | P26640 | |
| APLMQPPPHLEVQMA | 4631 | O75445 | |
| MSPLNVYPPGENHMG | 5086 | O75445 | |
| MVHMANPRQPLPASG | 226 | Q96L08 | |
| GIPRHSGPQYSMMQP | 601 | Q9UPN9 | |
| MMDGPGPRIPDHQRT | 2156 | Q9UQ35 | |
| RPPQAGLMPMQQQGF | 36 | Q9UMZ2 | |
| MHTKPNSQGPPNPMA | 726 | Q68EM7 | |
| PPAVPAGPQMDHMGN | 26 | Q6ZMB5 | |
| PEEMQRFMPPGDNVH | 626 | P58743 | |
| GRPAMDIPPIHPGMI | 751 | Q9Y520 | |
| HPGMIPPKPLMRRDQ | 761 | Q9Y520 | |
| PGGYPQDNMHQMHKP | 61 | P51532 | |
| VRPGMPSGARMPHQG | 26 | Q6STE5 | |
| EDPQEMPHSPLGSMP | 236 | Q9HB58 | |
| MAMGPPPTPHFNVLA | 546 | Q92922 | |
| PLMIPQANHMAGISP | 181 | P0DMB1 | |
| MPMQQARPAQPQEHP | 211 | Q15437 | |
| MPNRCGIIHVRGPMP | 636 | Q9BXP5 | |
| GMNPGQPTSMLSPRH | 476 | Q15596 | |
| SMISPPQDGRMGPHL | 181 | Q495C1 | |
| APRHHEMPNREPAGM | 21 | O60481 | |
| PLFPSIMMQPVQHPA | 2031 | Q86UP3 | |
| MDPGLQQALNGMAPP | 1 | P32971 | |
| GPFVSAMPTPMPHNK | 36 | Q9BTP6 | |
| PRNLGPTSSPMHRPM | 441 | A7XYQ1 | |
| GNHMMGQRQIPPYRP | 241 | Q15532 | |
| PHLQMPPSLGQMSLP | 721 | P42226 | |
| SPHNPNAPMMGPHGQ | 131 | Q9BWG4 | |
| NAPMMGPHGQPFMSP | 136 | Q9BWG4 | |
| PRPIMPNMVFIGGIN | 266 | P35504 | |
| FPQGMVMFNHRLPPV | 46 | Q9Y2X9 | |
| PPVVHLPGQPQRMMG | 1856 | Q92576 | |
| LPGQPQRMMGPLSQA | 1861 | Q92576 | |
| TLPQHMLQMLQPGPK | 236 | Q96DC7 | |
| QVLPTARPSPHGMEM | 486 | Q96JG9 | |
| GPPVPGSLNYNIMMH | 141 | Q96JM2 | |
| PRPQDMHGPQGMQRH | 666 | Q9C0J8 | |
| SHPQMAAMRPRGQPA | 151 | O94900 | |
| RGQPADIRQQPGMMP | 161 | O94900 | |
| MMIPPHRLDNPGQGG | 281 | P10600 | |
| PRPIMPNMVFIGGIN | 266 | P22310 | |
| EPMRMPAQHPLATVG | 856 | Q8N5Q1 | |
| GLTPPQMPGDHMNPY | 336 | O60663 |